Sources: 44NIH Clinical Center, 4ClinicalTrials, 15FDA, 41NCI, 13DrugBank, 65UMLS, 43NDF-RT, 26HMDB, 9DGIdb, 53PharmGKB, 30IUPHAR, 47Novoseek, 1BitterDBSee all MalaCards sources |
FDA approved drugs:
| id |
|
Drug Name |
Active Ingredient(s)15 |
Company |
Approval Date |
| 1 |
|
Erbitux15 41 |
CETUXIMAB |
Imclone, Bristol-Myers Squibb |
February 2004 |
Disease/s that Drug Treats:Colorectal Cancer
Indications and Usage:15 Erbitux® is an epidermal growth factor receptor (EGFR) antagonist indicatedfor treatment of:Head and Neck Cancer Locally or regionally advanced squamous cell carcinoma of the headand neck in combination with radiation therapy. (1.1, 14.1) Recurrent locoregional disease or metastatic squamous cell carcinomaof the head and neck in combination with platinum-based therapy with5-FU. (1.1, 14.1) Recurrent or metastatic squamous cell carcinoma of the head and neckprogressing after platinum-based therapy. (1.1, 14.1)Colorectal CancerK-Ras wild-type, EGFR-expressing, metastatic colorectal cancer asdetermined by FDA-approved tests in combination with FOLFIRI for first-line treatment, in combination with irinotecan in patients who are refractory toirinotecan-based chemotherapy, as a single agent in patients who have failed oxaliplatin- andirinotecan-based chemotherapy or who are intolerant to irinotecan.(1.2, 5.7, 12.1, 14.2)Limitation of Use: Erbitux is not indicated for treatment of Ras-mutantcolorectal cancer. (5.7, 14.2)
DrugBank Targets:13 1. Epidermal growth factor receptor;2. Low affinity immunoglobulin gamma Fc region receptor III-B;3. Complement C1r subcomponent;4. Complement C1q subcomponent subunit A;5. Complement C1q subcomponent subunit B;6. Complement C1q subcomponent subunit C;7. Low affinity immunoglobulin gamma Fc region receptor III-A;8. Complement C1s subcomponent;9. High affinity immunoglobulin gamma Fc receptor I;10. Low affinity immunoglobulin gamma Fc region receptor II-a;11. Low affinity immunoglobulin gamma Fc region receptor II-b;12. Low affinity immunoglobulin gamma Fc region receptor II-c
Mechanism of Action:15
Target: binding of epidermal growth factor (EGF) and other ligands to epidermal growth factor receptor (EGFR, HER1, c-ErbB-1)
Action: inhibitor
FDA: The epidermal growth factor receptor (EGFR, HER1, c-ErbB-1) is a transmembraneglycoprotein that is a member of a subfamily of type I receptor tyrosine kinases including EGFR,HER2, HER3, and HER4. The EGFR is constitutively expressed in many normal epithelialtissues, including the skin and hair follicle. Expression of EGFR is also detected in many humancancers including those of the head and neck, colon, and rectum. Cetuximab binds specifically to the EGFR on both normal and tumor cells, and competitivelyinhibits the binding of epidermal growth factor (EGF) and other ligands, such as transforminggrowth factor-alpha. In vitro assays and in vivo animal studies have shown that binding ofcetuximab to the EGFR blocks phosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, and decreased matrixmetalloproteinase and vascular endothelial growth factor production. Signal transduction throughthe EGFR results in activation of wild-type Ras proteins, but in cells with activating Ras somaticmutations, the resulting mutant Ras proteins are continuously active regardless of EGFRregulation.In vitro, cetuximab can mediate antibody-dependent cellular cytotoxicity (ADCC) against certainhuman tumor types. In vitro assays and in vivo animal studies have shown that cetuximabinhibits the growth and survival of tumor cells that express the EGFR. No anti-tumor effects ofcetuximab were observed in human tumor xenografts lacking EGFR expression. The addition ofcetuximab to radiation therapy or irinotecan in human tumor xenograft models in mice resultedin an increase in anti-tumor effects compared to radiation therapy or chemotherapy alone.
|
| 2 |
|
Evista15 41 |
RALOXIFENE HYDROCHLORIDE |
Eli Lilly |
September 2007 |
Disease/s that Drug Treats:osteoporosis and reduction of breast cancer risk in postmenopausal women
Indications and Usage:15 EVISTA is an estrogen agonist/antagonist indicated for Treatment and prevention of osteoporosis in postmenopausal women.(1.1)
DrugBank Targets:13 1. Estrogen receptor;2. Estrogen receptor beta
Mechanism of Action:15
Target: estrogenic pathways
Action: can be an activator or antooagonist
FDA: Decreases in estrogen levels after oophorectomy or menopause lead to increases in bone resorption andaccelerated bone loss. Bone is initially lost rapidly because the compensatory increase in bone formation isinadequate to offset resorptive losses. In addition to loss of estrogen, this imbalance between resorption andformation may be due to age-related impairment of osteoblasts or their precursors. In some women, these changeswill eventually lead to decreased bone mass, osteoporosis, and increased risk for fractures, particularly of the spine,hip, and wrist. Vertebral fractures are the most common type of osteoporotic fracture in postmenopausal women.The biological actions of raloxifene are largely mediated through binding to estrogen receptors. This bindingresults in activation of certain estrogenic pathways and blockade of others. Thus, raloxifene is an estrogenagonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM).Raloxifene decreases resorption of bone and reduces biochemical markers of bone turnover to thepremenopausal range. These effects on bone are manifested as reductions in the serum and urine levels of boneturnover markers, decreases in bone resorption based on radiocalcium kinetics studies, increases in bone mineraldensity (BMD), and decreases in incidence of fractures.
|
| 3 |
|
Istodax15 41 |
ROMIDEPSIN |
Gloucester Pharmaceuticals |
November 2009 |
Disease/s that Drug Treats:cutaneous T-cell lymphoma
Indications and Usage:15 ISTODAX is a histone deacetylase (HDAC) inhibitor indicated for: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who havereceived at least one prior systemic therapy (1). Treatment of peripheral T-cell lymphoma (PTCL) in patients who havereceived at least one prior therapy (1).These indications are based on response rate. Clinical benefit such asimprovement in overall survival has not been demonstrated (1).
Mechanism of Action:15
Target: histone deacetylase (HDAC)
Action: inhibitor
FDA: Romidepsin is a histone deacetylase (HDAC) inhibitor. HDACs catalyze the removal of acetyl groups from acetylated lysine residues in histones, resulting in themodulation of gene expression. HDACs also deacetylate non-histone proteins, such as transcription factors. In vitro, romidepsin causes the accumulation of acetylatedhistones, and induces cell cycle arrest and apoptosis of some cancer cell lines with IC50 values in the nanomolar range. The mechanism of the antineoplastic effect ofromidepsin observed in nonclinical and clinical studies has not been fully characterized.
|
| 4 |
|
Treanda15 41 |
BENDAMUSTINE HYDROCHLORIDE |
Cephalon |
October 2008 |
Disease/s that Drug Treats:Chronic lymphocytic leukemia and B-cell non-Hodgkinâs lymphoma
Indications and Usage:15 TREANDA is an alkylating drug indicated for treatment of patients with: Chronic lymphocytic leukemia (CLL). Efficacy relative to first linetherapies other than chlorambucil has not been established. (1.1) Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed duringor within six months of treatment with rituximab or a rituximab-containingregimen. (1.2)
DrugBank Targets: -
Mechanism of Action:15
Target: -
Action: -
FDA: Bendamustine is a bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring.Mechlorethamine and its derivatives form electrophilic alkyl groups. These groups form covalent bonds with electronrichnucleophilic moieties, resulting in interstrand DNA crosslinks. The bifunctional covalent linkage can lead to celldeath via several pathways. Bendamustine is active against both quiescent and dividing cells. The exact mechanism ofaction of bendamustine remains unknown.
|
Drugs for Spiradenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 908)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Azathioprine | approved | Phase 4, Phase 2 | 153 | 446-86-6 | 2265 | 446-86-6 55774-33-9 (hydrochloride salt) 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(Methyl-p-nitro-5-imidazolyl)thiopurine 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine A 4638 A2593_SIAL A4638_SIAL A4638_SIGMA AB00443544 AB00443544-03 AC-4230 AC1L1DAL AC1Q3Z1F AI-981/34845012 AI3-50290 Azamun Azamun [Czech] Azanin Azasan Azasan (TN) Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine Azathioprin Azathioprine Azathioprine (JP15/USP/INN) Azathioprine Sodium Azathioprine [USAN:INN:BAN:JAN] Azathioprine sodium Azathioprinum Azathioprinum [INN-Latin] Azathiopurine Azatioprin Azatioprina Azatioprina [INN-Spanish] Azothioprine B. W. 57-322 BPBio1_000054 BRD-K32821942-001-05-6 BRD-K60324116-001-01-5 BSPBio_000048 BSPBio_001876 BW 57-322 BW 57322 BW-57-322 C06837 C9H7N7O2S CAS-446-86-6 CBDivE_013132 CCRIS 62 CHEBI:2948 CHEMBL1542 CID2265 CPD000427366 Ccucol ChemDiv1_002659 Cytostatics D00238 DB00993 DivK1c_000586 EINECS 207-175-4 EU-0100027 FT-0083532 HMS1568C10 | HMS1920E17 HMS2091K19 HMS501N08 HMS594I19 HSDB 7084 IDI1_000586 Immuran Imuran Imuran (TN) Imuran (tn) Imurek Imurel KBio1_000586 KBio2_000464 KBio2_002427 KBio2_003032 KBio2_004995 KBio2_005600 KBio2_007563 KBio3_001376 KBio3_002906 KBioGR_000646 KBioGR_002427 KBioSS_000464 KBioSS_002433 LS-123 Lopac-A-4638 Lopac0_000027 MLS001049307 Methylnitroimidazolylmercaptopurine MolPort-000-745-914 MolPort-000-764-262 MolPort-003-665-485 Muran NCGC00015060-01 NCGC00015060-02 NCGC00015060-04 NCGC00015060-12 NCGC00090836-01 NCGC00090836-02 NCGC00090836-03 NCGC00090836-04 NCGC00090836-05 NCGC00090836-06 NCGC00094593-01 NCGC00094593-02 NCGC00094593-03 NCI-C03474 NINDS_000586 NSC 39084 NSC-39084 NSC39084 Oprea1_375441 Oprea1_533384 Oprea1_633462 Prestwick0_000094 Prestwick1_000094 Prestwick2_000094 Prestwick3_000094 Prestwick_41 S1721_Selleck SAM002589938 SDCCGMLS-0065415.P001 SMR000427366 SPBio_000255 SPBio_001987 SPECTRUM1500133 STK831906 STOCK1S-20293 STOCK1S-27186 Spectrum2_000068 Spectrum3_000308 Spectrum4_000243 Spectrum5_000848 Spectrum_000064 Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) UNII-MRK240IY2L WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW ZINC04258316 [Methyl(nitroimidazolyl)mercaptopurine] azathioprine azatiopr in cMAP_000046 |
| | 2 | | Chlorambucil | approved | Phase 4 | 52 | 305-03-3 | 2708 | 23125_FLUKA 305-03-3 4-(P-Bis(beta-chloroethyl)aminophenyl)butyric acid 4-(p-bis(β-chloroethyl)aminophenyl)butyric acid 4-[p-[bis(2-chloroethyl)amino]phenyl]butyric acid AB00051938 AC1L1EAB AC1Q75DO AI3-26083 Ambochlorin Amboclorin BPBio1_001208 BRD-K29458283-001-05-9 BRN 0999011 BSPBio_001098 BSPBio_001971 C 0253 C0253_SIGMA C14H19Cl2NO2 CAS-305-03-3 CB 1348 CB-1348 CB1348 CCRIS 126 CHEBI:28830 CHEMBL515 CHLORAMBUCIL CID2708 CPD000058372 Cb l348 Chlocambucil Chloorambucol Chlorambucil (USP/INN) Chlorambucil [INN:BAN] Chlorambucilum Chlorambucilum [INN-Latin] Chloraminophen Chloraminophene Chlorbutin Chlorbutine Chlorbutinum Chloroambucil Chlorobutin Chlorobutine Clorambucile Clorambucile [DCIT] Clorambucilo Clorambucilo [INN-Spanish] D00266 D002699 DB00291 DivK1c_000688 EINECS 206-162-0 EU-0100227 Ecloril Elcoril Elcorin FT-0083565 Glaxo Wellcome Brand of Chlorambucil GlaxoSmithKline Brand of Chlorambucil HMS1571G20 HMS1920M15 HMS2090M19 HMS2091A22 HMS502C10 HSDB 3026 IDI1_000688 KBio1_000688 KBio2_000558 | KBio2_003126 KBio2_005694 KBio3_001191 KBioGR_000766 KBioSS_000558 LEUKERAN (TN) LS-1158 Leuk ersan Leukeran Leukeran tablets Leukersan Leukoran Linfolizin Linfolysin Lopac-C-0253 Lopac0_000227 Lympholysin MLS000028443 MLS001076130 MolPort-000-152-694 N,N-Di-2-chloroethyl-gamma-P-aminophenylbutyric acid N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid NCGC00015199-01 NCGC00015199-02 NCGC00015199-03 NCGC00015199-07 NCGC00015199-14 NCGC00023250-00 NCGC00023250-03 NCGC00023250-04 NCGC00023250-05 NCGC00023250-06 NCGC00023250-07 NCGC00023250-08 NCGC00023250-09 NCGC00023250-10 NCI-C03485 NCI60_002639 NINDS_000688 NSC 3088 NSC-3088 NSC3088 Phenylbuttersaeure-lost Phenylbuttersaeure-lost [German] Phenylbutyric Acid Nitrogen Mustard Phenylbutyric acid nitrogen mustard Prestwick0_001079 Prestwick1_001079 Prestwick2_001079 Prestwick3_001079 RCRA waste no. U035 Rcra waste number U035 SAM002564202 SMR000058372 SPBio_000249 SPBio_002999 SPECTRUM1500171 ST50410766 Spectrum2_000065 Spectrum3_000336 Spectrum4_000273 Spectrum5_000677 Spectrum_000118 TL8002353 UNII-18D0SL7309 WLN: QV3R DN2G2G Wellcome Brand of Chlorambucil chlorambucil gamma-[P-Di(2-chloroethyl)aminophenyl]butyric acid γ-[p-di(2-chloroethyl)aminophenyl]butyric acid | |
| | 3 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 2643 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 DB00531 | DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide | |
| | 4 | | Daclizumab | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 96 | 152923-56-3 | | Anti-IL-2 Humanized antiCD25 | Ig gamma-1 chain C region Simulect chimeric mouse-human antiCD25 | |
| | 5 | | Indomethacin | approved, investigational | Phase 4 | 106 | 53-86-1 | 3715 | 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid 1z9h 37242-43-6 503560-73-4 53-86-1 74252-25-8 (hydrochloride salt, tri-hydrate) 7681-54-1 (hydrochloride salt) 91853-74-6 AB00052022 AC-532 AC1L1GJQ AKOS000592893 Aconip Aconip (TN) Amuno Apo-Indomethacin Arthrexin Artracin Artrinovo Artrivia BIDD:GT0132 BIM-0050670.0001 BPBio1_000160 BRD-K57222227-001-06-1 BRN 0497341 BSPBio_000144 BSPBio_001149 BSPBio_002176 Bio-0704 Bio2_000405 Bio2_000885 Bonidin Bonidon Bonidon Gel C01926 CAS-53-86-1 CCRIS 3502 CHEBI:49662 CHEMBL6 CID3715 CPD-10545 Catlep Chibro-amuno Chrono-indicid Chrono-indocid Confortid D00141 DB00328 DESMETHYL INDOMETHACIN DivK1c_000271 Dolcidium Dolcidium PL Dolovin Durametacin EINECS 200-186-5 EU-0100692 Elmetacin Flexin continus HMS1362I11 HMS1568H06 HMS1792I11 HMS1920F21 HMS1990I11 HMS2089N19 HMS2091N09 HMS500N13 HSDB 3101 Hicin I 7378 I0655 I7378_SIGMA I8280_SIGMA IDI1_000271 IDI1_002160 IMN IN1454 Idomethine Imbrilon Inacid Indacin Indameth Indmethacine Indo-Lemmon Indo-Spray Indo-phlogont Indo-rectolmin Indo-tablinen Indocid Indocid (pharmaceutical) Indocid Pda Indocid Sr Indocin Indocin (TN) Indocin I.V Indocin I.V. Indocin Sr Indolar SR Indomecol Indomed Indomee Indomet 140 Indometacin Indometacin (JP15/INN) Indometacina Indometacina [INN-Spanish] Indometacine Indometacine [INN-French] Indometacinum Indometacinum [INN-Latin] | Indometacyna Indometacyna [Polish] Indomethacin Indomethacin & MAP-30 Indomethacin (USP) Indomethacin Er Indomethacin [USAN:BAN] Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin Indomethacine Indomethacinum Indomethancin Indomethazine Indomethegan Indomethine Indometicina Indometicina [Spanish] Indomo Indomod Indoptic Indoptol Indorektal Indoxen Inflazon Infrocin Inteban sp KBio1_000271 KBio2_000489 KBio2_001399 KBio2_003057 KBio2_003967 KBio2_005625 KBio2_006535 KBio3_000897 KBio3_000898 KBio3_001396 KBioGR_000395 KBioGR_000489 KBioSS_000489 KBioSS_001399 L000959 LS-187 LS-82147 Lausit Liometacen Lopac-I-7378 Lopac0_000692 MLS000069402 MLS000758212 MLS001074194 Metacen Metartril Methazine Metindol Mezolin Miametan Mikametan Mobilan MolMap_000032 MolPort-000-917-894 NCGC00015562-01 NCGC00015562-02 NCGC00015562-03 NCGC00015562-08 NCGC00015562-19 NCGC00024135-02 NCGC00024135-04 NCGC00024135-05 NCGC00024135-06 NCGC00024135-07 NCGC00024135-08 NCGC00024135-09 NCGC00024135-11 NCI-C56144 NCI60_041708 NINDS_000271 Novo-Methacin Novomethacin Oprea1_686105 Prestwick0_000272 Prestwick1_000272 Prestwick2_000272 Prestwick3_000272 Prestwick_597 Reumacide Rhemacin LA Rheumacin LA S00108 S1723_Selleck SMR000058195 SMR000449290 SPBio_000979 SPBio_002363 SPECTRUM1500350 Sadoreum Spectrum2_000970 Spectrum3_000468 Spectrum4_000018 Spectrum5_000868 Spectrum_000919 Tannex Tivorbex Tocris-1708 UNII-XXE1CET956 UPCMLD-DP023 UPCMLD-DP023:001 USAN Vonum indometacin indomethacin nchembio.147-comp11 {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid |
| | 6 | | Memantine | approved, investigational | Phase 4, Phase 2 | 172 | 19982-08-2 | 4054 | 1,3-Dimethyl-5-adamantanamine 1-Amino-3,5-dimethyladamantane 19982-08-2 3,5-Dimethyl-1-adamantanamine 3,5-Dimethyl-1-adamantylamine 3,5-Dimethyl-1-aminoadamantane 3,5-Dimethyladamantan-1-ylamine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine 3,5-dimethyladamantan-1-amine 3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine 41100-52-1 (Hydrochloride) 51052-62-1 AB00053600 AC1L1HB7 AKOS000113995 BBL000737 BPBio1_001117 BPBio1_001270 BSPBio_001015 Biomol-NT_000209 C13736 CBMicro_020348 CHEBI:152523 CHEMBL807 CID4054 D08174 DB01043 DMAA DivK1c_000068 EU-0053634 Ebixa Exiba Exiba (TN) HMS500D10 HSDB 7327 IDI1_000068 KBio1_000068 KBio2_001087 KBio2_003655 | KBio2_006223 KBio3_001926 KBioGR_001543 KBioSS_001087 LS-157051 Lopac0_000861 Memantin Memantina Memantina [INN-Spanish] Memantine Memantine (INN) Memantine HCL Memantine Hydrochloride Memantine [INN:BAN] Memantine [INN] Memantinum Memantinum [INN-Latin] MolPort-002-041-858 NCGC00015705-05 NCGC00024782-02 NCGC00024782-03 NINDS_000068 Namenda Oprea1_480562 Prestwick0_000978 Prestwick1_000978 Prestwick2_000978 Prestwick3_000978 SPBio_001456 SPBio_002926 ST057652 STK520682 Spectrum2_001408 Spectrum3_000923 Spectrum4_001022 Spectrum5_001355 Spectrum_000607 UNII-W8O17SJF3T ZERO/006024 memantine | |
| | 7 | | Dorzolamide | approved | Phase 4, Phase 2, Phase 3 | 64 | 120279-96-1 | 3154, 5284549 | (4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide (4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide (4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide (4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide (4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE (4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide 120279-96-1 1cil 4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide 4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide 4S,6S-Dorzolamide AB00514687 AC1NR4NP BIDD:GT0306 BPBio1_001377 BRD-K48617017-003-03-1 BSPBio_001252 C06969 CHEBI:4702 | CHEMBL218490 CID5284549 D07871 DB04507 Dorzolamid Dorzolamida Dorzolamide Dorzolamide (DZA) Dorzolamide (INN) Dorzolamide Hydrochloride Dorzolamidum HMS2089O06 MolPort-005-941-739 Prestwick0_001116 Prestwick1_001116 Prestwick2_001116 Prestwick3_001116 SPBio_003116 STK645522 Trusopt Trusopt (TN) dorzolamide |
| | 8 | | Alcaftadine | approved | Phase 4, Phase 3 | 8 | 147084-10-4 | 19371515 | 6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b][3]benzazepine-3-carboxaldehyde Alcaftadina | Alcaftadinum Lastacaft Vilasta | |
| | 9 | | Difluprednate | approved | Phase 4, Phase 3, Phase 2 | 17 | 23674-86-4 | 443936 | | Difluoroprednisolone butyrate acetate Durezol | |
| | 10 | | Gabapentin | approved, investigational | Phase 4, Phase 2, Phase 1 | 269 | 60142-96-3 | 3446 | 1-(Aminomethyl)-cyclohexaneacetic acid 1-(Aminomethyl)cyclohexaneacetic acid 2-[1-(aminomethyl)cyclohexyl]acetic acid 60142-96-3 AC-1485 AC1L1FYE AC1Q53PH AKOS000280865 Aclonium Apo-Gabapentin Apotex brand of gabapentin Aventis brand of gabapentin BB_SC-1512 BIDD:GT0656 BPBio1_000993 BRN 2359739 BSPBio_000901 C040029 C9H17NO2 CAS-60142-96-3 CCRIS 7210 CHEBI:188316 CHEBI:42797 CHEMBL940 CI 945 CI-945 CID3446 D00332 DB00996 DDS-2003 DM-1796 DM-5689 EINECS 262-076-3 EU-0100582 G-154 G0318 G154_SIGMA GBN GOE 2450 Gabapen Gabapentin Gabapentin (JAN/USAN/INN) Gabapentin GR Gabapentin Hexal Gabapentin Kit Gabapentin Stada Gabapentin [USAN:INN:BAN] Gabapentin-ratiopharm Gabapentina Gabapentine Gabapentine [INN-French] Gabapentino Gabapentino [INN-Spanish] Gabapentino [Spanish] Gabapentinum | Gabapentinum [INN-Latin] Gabapetin Go 3450 Goe-3450 Gralise Gralise Starter Pack HMS1570N03 HMS2089J03 HSDB 7364 Hexal brand of gabapentin I06-0677 L000733 LS-7194 Lopac-G-154 Lopac0_000582 MLS000069358 MolPort-000-883-862 NCGC00015466-01 NCGC00015466-02 NCGC00015466-06 NCGC00015466-09 NCGC00016891-01 NCGC00021545-02 NCGC00021545-04 NCGC00021545-05 NSC742194 Neurontin Neurontin (TN) Novo-Gabapentin Novo-Gabapentine Novopharm brand of gabapentin PMS-Gabapentin Parke Davis brand of gabapentin Pfizer brand of gabapentin Pharmascience brand of gabapentin Prestwick0_000861 Prestwick1_000861 Prestwick2_000861 Prestwick3_000861 Prestwick_151 S2133_Selleck SMR000058311 SPBio_002822 STK598009 Serada Stadapharm brand of gabapentin TL8003814 Tocris-0806 UNII-6CW7F3G59X Vultin Warner-Lambert brand of gabapentin [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID gabapentin gabapentin (Neurontin) gabapentina gabapentinium ratiopharm brand of gabapentin |
| | 11 | | Fluocinolone Acetonide | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1, Phase 0 | 39 | 67-73-2 | 6215 | (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one 4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one 6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide 6.Alpha., 9.alpha.-Difluoro-16.alpha.-h 6.Alpha.,9-Difluoro 6.alpha.,9-Difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone 6.alpha.,9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide 6.alpha.-Fluorotriamcinolone acetonide 67-73-2 6a,9a-difluoro-16a-hydroxyprednisolone 16,17-acetonide 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-Acetonide 6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide 6alpha-Fluorotriamcinolone acetonide AC-429 AC1L1M1L AC1Q6ACL AR-1H0758 Acetonida de fluocinolona Acetonida de fluocinolona [INN-Spanish] Acetonide de fluocinolone Acetonide de fluocinolone [INN-French] Acetonido de fluocinolona Acetónida de fluocinolona Acétonide de fluocinolone C24H30F2O6 CCRIS 3250 CHEMBL989 CID6215 CPD000058329 Capex Coriphate Cortiplastol D01825 DB00591 Derma-smoothe/fs Dermalar Dermatin (steroid) Dermotic EINECS 200-668-5 F0657 F8880_FLUKA F8880_SIGMA FLUOCINOLONE ACETONIDE FS Flucinar Flucinolone Flucort Fluocet Fluocet (TN) Fluocinolon acetonid Fluocinolonacetonid Fluocinolonacetonidum Fluocinolone 16,17-acetonide Fluocinolone Acetonide Fluocinolone Acetonide 0.01% Fluocinolone acetonide (JP15/USP/INN) | Fluocinolone acetonide [DCIT] Fluocinolone acetonide [USAN:INN:JAN] Fluocinoloni acetonidum Fluocinoloni acetonidum [INN-Latin] Fluonid Fluortriamcinolone Acetonide Fluotrex Fluovitif Flupollon Fluzon Fs Shampoo HMS2090I14 HSDB 3083 Iluvien Jellin LS-118443 Localyn Localyn Syntex MLS000028545 MLS001076276 Medidur MolPort-002-528-328 NCGC00021301-04 NCI60_042042 NSC 92339 NSC92339 Neo-Synalar Omniderm Percutina Pregna-1,4-diene-3,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI) Prodermin RS 1401AT RS-1401 AT Radiocin Retisert Retisert (TN) S2470_Selleck SAM002564208 SMR000058329 STOCK1N-55828 Sinalar Synalar Synalar (TN) Synalar Ts Synalar-HP Synamol Synandone Synandrone Synemol Synotic Synsac Tefunote UNII-0CD5FD6S2M WLN: T F5 E5 B666 GO IO RV AHTTTT&J A BF CQ E FVIQ H H OF -A&BHO -B&ACEF ZINC03977981 component of Neo-Synalar flucinolone ydroxyprednisolone 16,17-acetonide |
| | 12 | | Infliximab | approved | Phase 4, Phase 3, Phase 1, Phase 2 | 349 | 170277-31-3 | | Ig gamma-1 chain C region | Inflectra Remicade Remsima |
| | 13 | | Desloratadine | approved, investigational | Phase 4 | 69 | 100643-71-8 | 124087 | 100643-71-8 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine AC-1279 AC1L3XUD AKOS000280921 Aerius Allex Azomyr BB_SC-2104 C121345 CHEBI:291342 CHEMBL1172 CID124087 CPD000149358 Claramax Clarinex Clarinex (TN) Clarinex RediTabs Clarinex Reditabs D03693 D3787 DB00967 DESLORATADINE Denosin Desalex Descarboethoxyloratadine Descarboethoxyoratidine | Desloratadine Desloratadine (USAN/INN) Desloratadine [USAN] Desloratidine Essex brand of desloratadine HMS2052H05 HMS2090C06 HMS2093F19 I06-1866 L001025 LS-181814 MLS000559042 MLS000759406 MLS001201801 MolPort-000-883-875 NCGC00159325-02 NCGC00159325-03 NCGC00159325-04 NSC675447 NeoClarityn Neoclarityn Opulis SAM001246545 SMR000149358 STK586537 Sch 34117 Sch-34117 Schering brand of desloratadine Schering-Plough brand of desloratadine TL8000065 UNII-FVF865388R desloratadine |
| | 14 | | Betamethasone | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 153 | 378-44-9 | 9782 | .beta.-Methasone .beta.-Methasone alcohol 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione 16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione 24024-03-1 34166_FLUKA 34166_RIEDEL 378-44-9 4-08-00-03501 (Beilstein Handbook Reference) 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-16.beta.-methylprednisolone 9-Fluoro-16beta-methylprednisolone 9-Fluoro-16β-methylprednisolone 9-alpha-Fluoro-16-beta-methylprednisolone 9.alpha.-Fluoro-16.beta.-methylprednisolone 9alpha-Fluoro-16 beta-methyl-prednisolone 9alpha-Fluoro-16beta-methylprednisolone 9α-Fluoro-16β-methylprednisolone AC1L1EYE AC1L1TT4 AC1Q5HJZ AKOS001582690 AR-1A7284 AR-1H5595 B1837 B7005_SIAL B7005_SIGMA B9675_SIAL BIDD:PXR0047 BPBio1_000533 BRD-A35108200-001-04-7 BRD-K39188321-001-03-9 BRN 3176546 BSPBio_000483 Bebate Becort Bedifos Betacorlan Betacortril Betadexamethasone Betafluorene Betamamallet Betametasona Betametasona [INN-Spanish] Betametasone Betametasone [DCIT] Betamethasone Betamethasone (JP15/USP/INN) Betamethasone Base Betamethasone Dipropionate Betamethasone Valearate Betamethasone Valerate Betamethasone [USAN:BAN:INN:JAN] Betamethasone [USAN:INN:BAN:JAN] Betamethasone alcohol Betamethasone cream Betamethasone dipropionate Betamethasone sodium phosphate Betamethasone valerate Betamethasonum Betamethasonum [INN-Latin] Betamethasonvalerat Mikron Betamethazone Betapredol | Betasolon Betnelan Betsolan C22H29FO5 CHEBI:3077 CHEMBL632 CID3003 CID9782 CPD000339803 Celestene Celeston Celestona Celestone Celestone Syrup and Tablets Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone Cellestoderm Cidoten D00244 D1961 DB00443 Desacort-Beta Diprolene EINECS 206-825-4 Flubenisolone HMS1569I05 HSDB 3015 Hormezon I06-0121 KST-1A3042 LS-118466 LT00441022 Luxiq Luxiqo MLS-0310139.0001 MLS000686794 MLS000859943 MLS001066413 MLS001332616 MLS002153244 Methazon MolPort-003-845-025 MolPort-007-981-051 NCGC00164401-01 NCGC00164401-02 NSC 39470 NSC-39470 NSC39470 Prestwick0_000362 Prestwick1_000362 Prestwick2_000362 Prestwick3_000362 Prestwick_703 Rinderon Rinderon (TN) Rinderon A S1500_Selleck SAM002589959 SCH 4831 SCH-4831 SMP1_000043 SMR000058601 SMR000339803 SPBio_002404 UNII-9842X06Q6M Valisone Visubeta ZINC03876136 beta-Methasone beta-Methasone alcohol betamethasone |
| | 15 | | Trimethoprim | approved | Phase 4, Phase 3 | 153 | 738-70-5 | 5578 | 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine 46984_FLUKA 46984_RIEDEL 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine 738-70-5 92131_FLUKA 92131_SIGMA AB00052118 AB1004879 AC-13572 AC1L1KNQ AC1Q48DF AI3-52594 AKOS001650069 ARONIS24118 AZT + TMP/SMX (mixture) combination Abacin Abaprim Alcorim-F Alprim Anitrim Antrima Antrimox Apo-Sulfatrim BB_SC-2116 BIDD:GT0190 BPBio1_000215 BRD-K07208025-001-06-5 BRN 0625127 BSPBio_000195 BSPBio_002245 BW 56-72 BW 5672 BW-56-72 Bacdan Bacidal Bacide Bacin Bacta Bacterial Bacterial [Antibiotic] Bacticel Bactin Bactoprim Bactramin Bactrim Bactrim DS Bactrim Pediatric Baktar Bencole Bethaprim Biosulten Briscotrim C01965 CAS-738-70-5 CCRIS 2410 CHEBI:45924 CHEMBL22 CID5578 CPD0-1581 CPD000035999 Chemotrim Chemotrin Cidal Co-Trimoxizole Co-trimoxazole Colizole Colizole DS Comox Conprim Cotrim Cotrim D.S. Cotrimel D00145 D014295 DB00440 Deprim DivK1c_000589 Drylin Duocide EINECS 212-006-2 EU-0101271 Esbesul Espectrin Euctrim Eusaprim Exbesul Fectrim Fermagex Fortrim Futin Gantaprim Gantrim HMS1568J17 HMS1921I03 HMS2090D14 HMS2092A10 HMS501N11 HSDB 6781 I06-0086 IDI1_000589 Idotrim Ikaprim Imexim Instalac Ipral KBio1_000589 KBio2_000647 KBio2_003215 KBio2_005783 KBio3_001465 KBioGR_000863 KBioSS_000647 KSC-4-158 KUC103659N Kepinol Kombinax LS-1627 Lagatrim Lagatrim Forte Laratrim Lastrim Lidaprim Linaris Lopac-T-7883 Lopac0_001271 MLS000079023 MLS001201740 MLS002303068 Methoprim Metoprim Microtrim MolPort-001-826-685 Monoprim Monotrim Monotrimin NCGC00016055-01 NCGC00016055-02 NCGC00016055-06 NCGC00016055-12 NCGC00024707-01 NCGC00024707-03 NCGC00024707-04 NCGC00024707-05 NCGC00024707-06 NCGC00024707-07 NCGC00024707-08 NIH 204 | NIH 204 (VAN) NINDS_000589 NSC 106568 NSC-106568 NSC106568 Nopil Novotrimel Omstat Oprea1_495058 Oraprim Pancidim Polytrim Prestwick0_000208 Prestwick1_000208 Prestwick2_000208 Prestwick3_000208 Prestwick_485 Priloprim Primosept Primsol Proloprim Proloprim (TN) Protrin Purbal Resprim Resprim Forte Roubac Roubal SAM002264649 SMP2_000262 SMR000035999 SPBio_000874 SPBio_002116 SPECTRUM1500595 STK177322 Salvatrim Septra Septra DS Septra Grape Septrin Septrin DS Septrin Forte Septrin S Setprin Sigaprim Sinotrim Smz-Tmp Spectrum2_000937 Spectrum3_000643 Spectrum4_000372 Spectrum5_001559 Spectrum_000167 Stopan Streptoplus Sugaprim Sulfamar Sulfamethoprim Sulfamethoprim-DS Sulfamethoxazole & Trimethoprim Sulfatrim Sulfatrim Pediatric Sulfatrim-DS Sulfatrim-SS Sulfotrim Sulfoxaprim Sulmeprim Sulmeprim Pediatric Sulprim Sulthrim Sultrex Sumetrolim Supracombin Suprim Syraprim T 7883 T2286 T7883_SIGMA TCMDC-125538 TL8005108 TMP/SMX (MIXTURE)) Teleprim Thiocuran Tiempe Tmp-Ratiopharm Tocris-0650 Toprim Trigonyl Trimanyl Trimesulf Trimeth/Sulfa Trimethioprim Trimethopim(TMP) Trimethoprim Trimethoprim & VRC3375 Trimethoprim (JAN/USP/INN) Trimethoprim [USAN:BAN:INN:JAN] Trimethoprime Trimethoprime [INN-French] Trimethoprimum Trimethoprimum [INN-Latin] Trimethopriom Trimetoprim Trimetoprim [DCIT] Trimetoprim [Polish] Trimetoprima Trimetoprima [INN-Spanish] Trimexazole Trimexol Trimez-IFSA Trimezol Trimogal Trimono Trimopan Trimpex Trimpex (TN) Trimpex 200 Triméthoprime Triprim Trisul Trisulcom Trisulfam Trisural U-Prin UNII-AN164J8Y0X UPCMLD-DP132 UPCMLD-DP132:001 Unitrim Uretrim Uro-D S Uro-Septra Urobactrim Uroplus Uroplus DS Uroplus SS Utetrin Velaten WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1 WR 5949 Wellcoprim Wellcoprin Xeroprim ZINC06627681 Zamboprim component of Bactrim component of Septra nchembio.108-comp1 nchembio.215-comp11 nchembio.221-comp23 trimethoprim | |
| | 16 | | Gatifloxacin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 31 | 112811-59-3 | 5379 | (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid 112811-59-3 160738-57-8 180200-66-2 AC-1944 AC1L1K82 AKOS004119932 AM 1155 AM-1155 AM-1155 (*Sesquihydrate*) BB_SC-1123 BMS 206584-01 BMS-206584 BMS-206584-01 BRD-A74980173-001-02-8 BSPBio_002697 Bonoq C07661 CG 5501 CG-5501 CHEBI:5280 CHEMBL31 CID5379 CPD000043336 D08011 DB01044 FT-0082686 GTFX Gaity Gatiflo Gatiflo,Tequin and Zymar, Gatifloxacin Gatifloxacin Gatifloxacin & Gamma Interferon Gatifloxacin (INN) Gatifloxacin (TN) Gatifloxacin [USAN:INN] Gatifloxacine Gatifloxacino Gatifloxacinum | Gatilox Gatiquin Gatispan HMS1922J15 HMS2090K10 HMS2093G06 I06-2286 I06-2287 KBio2_002442 KBio2_005010 KBio2_007578 KBio3_001917 KBioGR_001613 KBioSS_002448 Kinome_3137 LS-184402 MLS000040259 MLS000759493 MolPort-001-738-626 NCGC00095126-01 NCGC00095126-02 NCGC00178525-01 PD 135432 PD-135432 PD135432 S1340_Selleck S1340_Sellekc SAM001246715 SAM002589955 SMR000043336 SPBio_000353 SPECTRUM1504272 STK801620 Spectrum2_000487 Spectrum3_000999 Spectrum4_001127 Spectrum5_001468 Spectrum_001909 TL8001438 Tequin Tequin in dextrose 5% in plastic container Zymar Zymaxid Zymer Zymer (TN) | |
| | 17 | | Foscarnet | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 30 | 63585-09-1 | 3415 | 1nki 34156-56-4 4428-95-9 4428-95-9 (Parent) 63585-09-1 63585-09-1 (tri-hydrochloride salt) 79510_FLUKA A 29622 A-29622 AC-2085 AC1L1FVT AC1L2C37 AC1L5400 AC1NB82R AC1Q1UNV AR-1L5079 Ambap63585-09-1 BSPBio_003067 C06456 CHEBI:127780 CHEBI:141644 CHEBI:60269 CHEMBL666 CHEMBL754 CID169569 CID3415 CID44561 Carboxyphosphonic acid D00579 D02267 DB00529 DRG-0017 Dihydroxyphosphinecarboxylic acid oxide Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody Dihydroxyphosphinecarboxylic acid oxide trisodium salt Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate DivK1c_000915 EHB 776 EHB-776 FOSCARNET SODIUM Formic acid, phosphono-, trisodium salt, hexahydrate Forscarnet sodium Foscarmet Foscarnet Foscarnet & IFN-.ALPHA. Foscarnet Sodium Foscarnet sodico Foscarnet sodico [Spanish] Foscarnet sodique Foscarnet sodique [French] Foscarnet sodique [INN-French] Foscarnet sodium Foscarnet sodium (USAN/INN) Foscarnet sodium [USAN:INN:BAN] Foscarnet sodium hydrate Foscarnet sodium hydrate (JAN) Foscarneto sodico Foscarneto sodico [INN-Spanish] Foscarnetum natricum Foscarnetum natricum [INN-Latin] Foscarnetum natricum [Latin] Foscavir Foscavir (TN) HMS1921D18 HMS2092N15 | HMS502N17 HS-0008 IDI1_000915 KBio1_000915 KBio2_001839 KBio2_004407 KBio2_006975 KBio3_002567 KBioGR_001419 KBioSS_001839 LS-105952 LS-105953 LS-183979 LS-187063 LS-187793 MSL & PFA MolPort-003-665-560 MolPort-003-895-968 NCGC00094941-01 NCGC00094941-02 NChemBio.2007.9-comp7 NINDS_000915 NSC313410 P6801_ALDRICH P6801_SIGMA PFA & rIFN.alpha.A Phgosphonocarboxylic acid Phosphinecarboxylic acid, dihydroxy-, oxide Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate Phosphonoformate Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon Phosphonoformic acid Phosphonoformic acid & IFN-.ALPHA. Phosphonoformic acid trisodium salt hexahydrate Phosphonoformic acid, trisodium salt Phosphonoformic acid, trisodium salt, hexahydrate Phosphonomethanoic acid Prestwick_1024 SPBio_000735 SPECTRUM1502019 Sodium phosphonoformate tribasic hexahydrate Spectrum2_000668 Spectrum3_001484 Spectrum4_000840 Spectrum5_000932 Spectrum_001359 Triapten Trisodium carboxyphosphate Trisodium phosphonoformate Trisodium phosphonoformate hexahydrate Trisodium phosphonoformte hexahydrate UNII-364P9RVW4X UNII-964YS0OOG1 Virudin dihydroxyphosphanecarboxylic acid oxide foscarnet foscarnet sodium hexahydrate phosphonomethanoic acid sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6) trisodium carboxyphosphate (anhydrous) trisodium dioxidophosphanecarboxylate oxide trisodium dioxidophosphinecarboxylate oxide trisodium phosphonatoformate trisodium phosphonatoformate hexahydrate trisodium phosphonoformate (anhydrous) | |
| | 18 | | Epinephrine | approved | Phase 4, Phase 2, Phase 3 | 834 | 51-43-4 | 5816 | (-)-(R)-Epinephrine (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol (-)-Adrenalin (-)-Adrenaline (-)-Epinephrine (-)-R-Epinephrine (R)-(-)-Adnephrine (R)-(-)-Adrenaline (R)-(-)-Epinephrine (R)-(-)-Epirenamine (R)-(−)-adrenaline (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol (R)-Adrenaline (R)-Epinephrine (−)-adrenaline 02252_FLUKA 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol 1-Adrenalin 1-Epinephrine 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol 51-43-4 51-43-4 (FREE BASE) 51028-73-0 A0173 AC-13188 AC1L1L7B ADR ADRENALINE ADROP AI3-19015 Adnephrine Adrenaclick Adrenal Adrenalin Adrenalin (TN) Adrenalin in Oil Adrenalin-Medihaler Adrenalina Adrenalina [DCIT] Adrenaline Adrenaline (JP15) Adrenaline/Epinephrine Adrenalinum Adrenamine Adrenan Adrenapax Adrenasol Adrenatrate Adrenine Adrenodis Adrenohorma Adrenosan Adrenutol Adrin Adrine Ana-Guard Ana-Kit Antiasthmatique Asmatane Mist Asthma meter mist Asthma-nefrin Asthmahaler Mist Asthmanefrin Astmahalin Astminhal Auvi-q BIDD:GT0119 Balmadren Bernarenin Biorenine Bosmin Brevirenin Bronkaid Bronkaid Mist Bronkaid Suspension Mist Bupivacaine Hcl and Epinephrine C00788 CCRIS 4812 CHEBI:28918 CHEMBL679 CID5816 Chelafrin Citanest Forte Corisol D-Epifrin D-Epinephrine D00095 DB00668 Drenamist Dylephrin Dyspne-Inhal E4250_SIGMA EINECS 200-098-7 EPI E Z PEN JR EPIPEN E Z PEN EPIPEN JR Epi EZ Pen Jr Epifrin Epiglaufrin Epinefrin Epinefrin [Czech] Epinefrina Epinefrina [INN-Spanish] Epinephran Epinephrin Epinephrine Epinephrine (USP) Epinephrine (USP/INN) Epinephrine [USAN:INN:JAN] Epinephrine bitartrate Epinephrine chloride Epinephrine hydrochloride Epinephrinum Epinephrinum [INN-Latin] Epipen Epipen (TN) Epipen Auto-Injector Epipen EZ Pen Epipen Jr Epipen Jr. Epipen Jr. Auto-Injector Epipen jr Epirenamine Epirenan Epirenin Epitrate Eppy | Esphygmogenina Exadrin Glaucon Glaucosan Glauposine Glycirenan HSCI1_000215 HSDB 4289 Haemostasin Haemostatin Hektalin Hemisine Hemostasin Hemostatin Hypernephrin Hyporenin IOP Intranefrin Iontocaine Isoptoepinal Kidoline L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol L-Adrenaline L-Adrenaline Base L-Epinehphrine L-Epinephrine L-Epirenamine L-Methylaminoethanolcatechol L-epinephrine LS-156 Levo-Methylaminoethanolcatechol Levoadrenaline Levoepinephrine Levorenen Levorenin Levorenine Levoreninum Lopac-E-4642 Lyodrin Lyophrin Medihaler-Epi Metanephrin Methylaminoethanolcatechol Methylarterenol Micronefrin Micronephrine MolPort-002-051-368 Mucidrina Myosthenine Mytrate NCGC00015417-01 NCGC00142615-01 NCGC00142615-03 NCGC00142615-04 NCGC00142615-05 NCGC00142615-06 NCGC00142615-07 NSC 62786 NSC62786 Nephridine Nieraline PDSP1_001120 PDSP2_001104 Paranephrin Primatene Primatene Mist Primatene Mist Refill Prime Asthma Relief R-(-)-Epinephrine R-Adrenaline RCRA waste no. P042 Racemic Epinephrine Racepinephrine Rcra waste number P042 Renagladin Renaglandin Renaglandulin Renaleptine Renalina Renoform Renostypricin Renostypticin Renostyptin SMP1_000227 ST069368 SUS-PHRINE SULFITE-FREE Scurenaline Septocaine Simplene Sindrenina Soladren Sphygmogenin Stryptirenal Styptirenal Supracapsulin Supradin Supranefran Supranephrane Supranephrine Supranol Suprarenaline Suprarenin Suprel Surenine Surrenine Sus-Phrine Sus-phrine Susphrine Sympathin I Takamina Takamine Tokamina Tonogen Twinject Twinject 0.15 Twinject 0.3 Twinject 0.30 UNII-YKH834O4BH Vaponefrin Vasoconstrictine Vasoconstrictor Vasodrine Vasoton Vasotonin adrenaline bmse000316 d-Adrenaline epinephrine l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol l-Adrenalin l-Adrenaline l-Epinephine l-Epinephrine (synthetic) l-Epirenamine l-Methylaminoethanolcatechol levoepinephrine nchembio747-comp9 |
| | 19 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1444 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-Methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan Methopterin Methotextrate | Methotrate Methotrexat Methotrexate Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metoject Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Otrexup Rasuvo Rheumatrex Rheumatrex Dose Pack Trexall |
| | 20 | | Mycophenolic acid | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 898 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum Melbex | Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolic Acid Mycophenolsaeure Myfortic | |
| | 21 | | Ketotifen | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 21 | 34580-14-8 | 3827 | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1) 116655-74-4 34580-13-7 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one 4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one 4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one 4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one AB00053575 AC-15945 AC1L1GSZ AKOS000541268 Alaway Alaway (TN) Allergy Eye Allergy Eye Drops Allergy Eye original prescription strength Allergy Relief Eye Allergy Relief Eye Drops Antihistamine Eye BAS 00444483 BIDD:GT0509 BPBio1_000575 BRD-K28936863-051-05-8 BRN 3983897 BSPBio_000521 BSPBio_002964 C19H19NOS CAS-34580-14-8 CHEBI:112957 CHEMBL534 CID3827 Care One Allergy Eye Care One Eye Itch Relief D08105 DB00920 DivK1c_000111 EINECS 252-099-7 Equaline Eye Itch Relief Equate Eye Itch Relief Equate Itchy Eye Eye Itch Eye Itch Relief Good Neighbor Pharmacy Eye Itch Relief Good Neighbor Pharmacy Itchy Eye Good Sense Allergy Eye Good Sense Eye Itch Relief Good Sense Itchy Eye original prescription strength HC 20-511 HMS2090F16 HSDB 7283 Health Mart Eye Itch Relief IDI1_000111 Itchy Eye Itchy Eye Drops Itchy Eye Relief Itchy Eye original prescription strength | KBio1_000111 KBio2_000906 KBio2_003474 KBio2_006042 KBio3_002184 KBioGR_001289 KBioSS_000906 Ketotifen (INN) Ketotifen Fumarate Ketotifen [INN:BAN] Ketotifene Ketotifene [INN-French] Ketotifene fumarate Ketotifeno Ketotifeno [INN-Spanish] Ketotifenum Ketotifenum [INN-Latin] Ketotifin Ketotiphen Ketotiphene L000753 LS-33820 Leader Allergy Eye Leader Eye Itch Relief Drops Lopac-K-2628 Lopac0_000706 MolPort-001-933-278 NCGC00015580-01 NCGC00015580-02 NCGC00015580-03 NCGC00015580-09 NCGC00022572-02 NCGC00022572-04 NCGC00022572-05 NINDS_000111 Oprea1_335550 Oprea1_553550 Prestwick0_000371 Prestwick1_000371 Prestwick2_000371 Prestwick3_000371 SPBio_001275 SPBio_002442 STK048448 STOCK1S-14132 Smart Sense Allergy Spectrum2_001198 Spectrum3_001382 Spectrum4_000805 Spectrum5_001395 Spectrum_000426 Sunmark Eye Itch Relief Tocris-0784 Topcare Eye Itch Relief UNII-X49220T18G Wal Zyr Zaditor Zaditor Antihistamine Eye Drops ketotifen |
| | 22 | | Brinzolamide | approved | Phase 4, Phase 3, Phase 2 | 59 | 138890-62-7 | 68844 | (+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide (4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide (R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 138890-62-7 2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,R 3znc AB00513824 AC-5277 AC1L2AKA AC1Q6UVB AKOS005145708 AL 4862 AL-4862 AL04862 Alcon brand of brinzolamide Allphar brand of brinzolamide Azopt Azopt (TN) BIDD:GT0039 BPBio1_000539 BRD-K74913225-001-03-3 BSPBio_000489 BZ1 | Birnzolamide Brinzolamide Brinzolamide (BRZ) Brinzolamide (JAN/USP/INN) Brinzolamide [USAN] C07760 C111827 C12H21N3O5S3 CHEBI:3176 CHEMBL220491 CID68844 D00652 DB01194 FT-0082471 HMS1569I11 I09-0605 LS-173036 MLS002153787 MolPort-005-940-291 Prestwick0_000365 Prestwick1_000365 Prestwick2_000365 Prestwick3_000365 SMR001233169 SPBio_002410 UNII-9451Z89515 | |
| | 23 | | Interferon beta-1a | approved, investigational | Phase 4 | 194 | 145258-61-3 | 6438354 | 145258-61-3 Avonex Avonex (TN) Avonex Pen Belerofon D04554 Extavia | Fibroblast interferon IFN-beta Interferon beta precursor Interferon beta-1a Interferon beta-1a (USAN) Interferon beta-1a (genetical recombination) Interferon beta-1a (genetical recombination) (JAN) Rebif Rebif Rebidose |
| | 24 | | Tobramycin | approved, investigational | Phase 4, Phase 3 | 111 | 32986-56-4 | 5496, 36294 | 1-Epitobramycin 11098-01-4 11111-45-8 3'-Deoxykanamycin B 3'-Deoxykanamycin b 32986-56-4 34337-51-4 37321-13-4 49842-07-1 (Sulfate) 54330-95-9 70322-33-7 79645-27-5 A 12253A AB00513858 AC1L1KGY AC1L1VI0 AC1O7GFJ AC1Q2AOW AKOS000715235 Aktob BAS 00463364 BIDD:GT0503 BPBio1_000647 BRN 1357507 BSPBio_000587 BSPBio_002036 Bethkis Brulamycin C00397 C18H37N5O9 CAS-32986-56-4 CHEBI:28864 CHEBI:533587 CHEMBL1747 CID11340303 CID36294 CID5496 CID6604388 CID9804613 CID9934285 CPD000058793 D00063 DB00684 Deoxykanamycin B Distobram EINECS 251-322-5 Gotabiotic HMS1569N09 HMS2090B16 HMS2092M17 HSDB 3259 KBio2_001552 KBio2_004120 KBio2_006688 KBio3_001536 KBioGR_001104 KBioSS_001552 Kitabis Pak LS-146940 LS-187329 Lilly 47663 MLS000069544 MolPort-001-934-131 MolPort-003-665-548 MolPort-003-939-629 NCGC00016814-01 NCGC00178852-01 NCGC00178852-02 NEBRAMYCIN NF 6 NSC 180514 | NSC180514 Nebcin Nebcin (Sulfate) Nebicin Nebramycin 6 Nebramycin VI Nebramycin factir 6 Nebramycin factor 6 Nebramycin-Faktor 6 O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine Obracin Obramycin Prestwick0_000544 Prestwick1_000544 Prestwick2_000544 Prestwick3_000544 Prestwick_850 S2514_Selleck SAM001246911 SMR000058793 SPBio_000295 SPBio_002508 SPECTRUM1500579 SPRC-AB01 STK182610 Spectrum2_000078 Spectrum3_000588 Spectrum4_000752 Spectrum5_001038 Spectrum_001072 Sybryx T4014_SIGMA TOA-(1-6)2TB-(4-1)TOC TOA-(1-6)TOB-(4-1)TOC TOBRAMYCIN SULFATE TOY Tenebrimycin Tenemycin Tobacin Tobi Tobi Podhaler Tobracin Tobracin (TN) Tobracin (tn) Tobradex Tobradistin Tobralex Tobramaxin Tobramicin Tobramicina Tobramicina [INN-Spanish] Tobramitsetin Tobramycetin Tobramycin Tobramycin (JP15/USP) Tobramycin Sulfate Tobramycin [USAN:BAN:INN:JAN] Tobramycin for Inhalation Tobramycin solution for inhalation Tobramycin, Free Base Tobramycine Tobramycine [INN-French] Tobramycinum Tobramycinum [INN-Latin] Tobrased Tobrasone Tobrex Tobrex (TN) Tobrex (tn) UNII-VZ8RRZ51VK tobramycin tobramycin solution for inhalation | |
| | 25 | | Cidofovir | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 31 | 113852-37-2 | 60613 | (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine (S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine (S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid (S)-HPMPC (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid ({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine 1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine 113852-37-2 120362-37-0 (hydrochloride salt) 149394-66-1 AC-1666 AC1L1TLB AC1Q6C68 AKOS005145721 C8H14N3O6P CDV CHEBI:3696 | CHEMBL152 CID60613 Cidofovir Cidofovir (Vistide) Cidofovir (anhydrous) Cidofovir Anhydrous Cidofovir anhydrous Cidofovirum DB00369 Forvade GS 0504 GS 504 GS-0504 GS-504 GS504 HPMPC HSDB 7115 LS-106432 MolPort-005-935-597 NSC742135 S1516_Selleck UNII-768M1V522C Vistide Vistide, Cidofovir [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid [(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid |
| | 26 | | Ganciclovir | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 140 | 82410-32-0 | 3454 | 106931-35-5 107910-75-8 (mono-hydrochloride salt) 2'-NDG 2'-Nor-2'-deoxyguanosine 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one 2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one 82410-32-0 86357-12-2 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine 96551-29-0 AC-12604 AC1L1FZ2 AC1Q52OB AKOS004119898 BB_NC-1042 BIDD:GT0783 BIOLF-62 BPBio1_000877 BSPBio_000797 BW 759 BW 759U BW-759U BW-795 BW-B 759U Biolf 62 CAS-82410-32-0 CCRIS 9212 CHEBI:465284 CHEMBL182 CID3454 CPD000058324 Citovirax Cymevan Cymeven Cymevene Cytovene Cytovene (TN) Cytovene IV Cytovene-IV D00333 DB01004 DRG-0018 EU-0100539 | G 2536 G2536_SIGMA GA2 GANCICLOVIR SODIUM GCV & 1110U81 GCV & MSL Ganciclovir Ganciclovir & C34-dgA immunotoxin Ganciclovir & D5-dgA immunotoxin Ganciclovir (JAN/USP/INN) Ganciclovir Sodium Ganciclovir [USAN:INN:BAN:JAN] Ganciclovirum Ganciclovirum [Latin] Gancyclovir Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody HHEMG HMS1570H19 HMS2090K08 HSDB 6512 Hydroxyacyclovir I07-0010 IN1478 LS-73939 Lopac-G-2536 Lopac0_000539 MB3795 MLS000028481 MLS001077349 MolPort-000-758-398 MolPort-002-507-301 NCGC00015471-01 NCGC00015471-02 NCGC00015471-03 NCGC00015471-06 NCGC00093928-01 NCGC00093928-02 NCGC00168567-01 PDSP1_000816 PDSP2_000803 Prestwick0_000839 Prestwick1_000839 Prestwick2_000839 Prestwick3_000839 Prestwick_1068 RS-21592 SAM002548936 SMP2_000038 SMR000058324 SPBio_002718 ST-605 STK801910 UNII-P9G3CKZ4P5 Virgan Vitrasert Vitrasert (TN) ZINC00001505 Zirgan ganciclovir nchembio.87-comp3 | |
| | 27 | | Probenecid | approved | Phase 4, Phase 2, Phase 1 | 27 | 57-66-9 | 4911 | 4-((Dipropylamino)sulfonyl)benzoic acid 4-(Di-N-propylsulfamoyl)benzoesaeure 4-(Di-n-propylsulfamoyl)benzoesaeure 4-(Dipropylsulfamoyl)benzoic acid 4-(N,N-Dipropylsulfamoyl)benzoesaeure 4-[(dipropylamino)sulfonyl]benzoic acid 57-66-9 AB00052080 AC-2023 AC1L1J86 AC1Q2XQM AC1Q2XQN AI3-50078 AKOS000165123 Apurina BIDD:GT0626 BIDD:PXR0092 BPBio1_000643 BRD-K95237249-001-05-9 BRN 2815775 BSPBio_000583 BSPBio_002227 Bencid Benecid Benemid Benemid (TN) Benemide Benuryl Biokanol Brand of Probenecid C07372 C13H19NO4S CAS-57-66-9 CCRIS 3643 CHEBI:177474 CHEMBL897 CID4911 CPD000058280 Col-BENEMID Col-Probenecid ColBenemid (co mponent of) ColBenemid (component of) Colbenemid D00475 D011339 DB01032 DivK1c_000056 EINECS 200-344-3 HMS1569N05 HMS1920J22 HMS2092C03 HMS500C18 HSDB 3387 I01-1905 ICN Brand of Probenecid IDI1_000056 IDIS Brand of Probenecid KBio1_000056 KBio2_001314 KBio2_003882 KBio2_006450 KBio3_001727 KBioGR_000971 KBioSS_001314 LS-33 MLS000028496 MLS001076472 Major Brand of Probenecid Martec Brand of Probenecid Merck Brand of Probenecid MolPort-000-145-935 NCGC00016251-01 NCGC00016251-02 NCGC00023829-03 | NCGC00023829-04 NCGC00023829-05 NCGC00023829-06 NCI-C56097 NINDS_000056 NSC 18786 NSC18786 Ophthalmic Brand of Probenecid Oprea1_416955 P-(Dipropylsulfamoyl)benzoic acid P8761_SIGMA Panuric Parabenem Parmed Brand of Probenecid Polycillin-BRB Polycillin-PRB Polycillin-PRB (component of) Prestwick0_000542 Prestwick1_000542 Prestwick2_000542 Prestwick3_000542 Prestwick_809 Pro-Cid Probalan Probampacin Probecid Proben Proben-C Probenecid Probenecid (JP15/USP/INN) Probenecid Acid Probenecid Major Brand Probenecid Martec Brand Probenecid Parmed Brand Probenecid Weimer Probenecid Zenith Brand Probenecid [INN:BAN:JAN] Probenecid acid Probenecida Probenecida [INN-Spanish] Probenecide Probenecide [INN-French] Probenecidum Probenecidum [INN-Latin] Probenemid Probenicid Probenid Probexin Prolongine Robenecid SAM002554923 SBB028597 SMR000058280 SPBio_001327 SPBio_002504 SPECTRUM1500502 Spectrum2_001294 Spectrum3_000554 Spectrum4_000486 Spectrum5_001419 Spectrum_000834 Sulprin Synergid R Tubophan UNII-PO572Z7917 Uricosid Urocid Valdecasas Brand of Probenecid WLN: QVR DSWN3&3 Zenith Brand of Probenecid p-(Dipropylsulfamoyl)benzoic acid p-(Dipropylsulfamyl)benzoic acid p-[Dipropylsulfamoyl]benzoic acid probenecid probenicid |
| | 28 | | Tacrolimus | approved, investigational | Phase 4, Phase 2, Phase 3 | 1023 | 104987-11-3 | 445643, 439492, 445647 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN 8-DEETHYL-8-[but-3-enyl]-ascomycin AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 FR900506 | FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 Hecoria IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus Hydrate Tacrolimus anhydrous Tacrolimus hydrate Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 29 | | Mitoxantrone | approved, investigational | Phase 4 | 257 | 65271-80-9 | 4212 | 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione 137635-96-2 2fum 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone 65271-80-9 70476-82-3 70476-82-3 (hydrochloride) 70711-41-0 70711-41-0 (acetate) 70945-62-9 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI) AB00053716 AC1L1HNY AN-584/42007670 BIDD:PXR0181 BPBio1_000627 BRD-K21680192-300-05-2 BRD-K21680192-300-07-8 BRN 2795126 BSPBio_000569 BSPBio_003160 C11195 C22H28N4O6 CAS-70476-82-3 CCRIS 7604 CHEBI:50729 CHEMBL58 CID4212 D08224 DB01204 DHAD DHAQ DHAQ (*Diacetate salt*) DHAQ HCl Dihydroxyanthraquinone DivK1c_000516 HMS2090D05 IDI1_000516 KBio1_000516 KBio2_002135 KBio2_004703 KBio2_007271 KBio3_002660 KBioGR_001531 KBioSS_002135 LS-20638 Liposome Encapsulated Mitoxantrone (LEM) Lopac-M-6545 Lopac0_000779 MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE MIX MLS002703044 | Misostol Misostol (TN) Mitox Mitoxanthrone Mitoxantron Mitoxantrona Mitoxantrona [INN-Spanish] Mitoxantrone Mitoxantrone (INN) Mitoxantrone (free base) Mitoxantrone 2HCl Mitoxantrone HCl Mitoxantrone Hydrochloride Mitoxantrone [INN] Mitoxantrone dihydrochloride Mitoxantrone hydrochloride Mitoxantronum Mitoxantronum [INN-Latin] Mitozantrone Mitozantrone hydrochloride MolPort-003-849-239 NCGC00015693-01 NCGC00015693-02 NCGC00015693-04 NCGC00162251-01 NCI60_002276 NCI60_002535 NChemBio.2007.10-comp17 NINDS_000516 NSC 279836 NSC-279836 NSC-287836 NSC-299195 NSC-301739 NSC-301739D NSC279836 NSC299195 NSC301739 Neuro_000153 Novantron Novantrone Novantrone(R) (mitoxantrone for injection concentrate) Prestwick0_000385 Prestwick1_000385 Prestwick2_000385 Prestwick3_000385 S2485_Selleck SMP2_000179 SMR001549953 SPBio_000756 SPBio_002490 SR-01000076001 SR-01000076001-7 STK631833 Spectrum2_000908 Spectrum3_001590 Spectrum4_000866 Spectrum5_001205 Spectrum_001655 UNII-BZ114NVM5P VU0244399-2 mitoxantrone | |
| | 30 | | Lidocaine | approved | Phase 4, Phase 2, Phase 3 | 1103 | 137-58-6 | 3676 | .alpha.-(Diethylamino)-2,6-acetoxylidide .alpha.-Diethylamino-2,6-dimethylacetanilide .alpha.-Diethylaminoaceto-2,6-xylidide .omega.-Diethylamino-2,6-dimethylacetanilide 137-58-6 2-(Diethylamino)-2',6'-acetoxylidide 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide 4-12-00-02538 (Beilstein Handbook Reference) 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)) 6108-05-0 (mono-hydrochloride, mono-hydrate) 73-78-9 (mono-hydrochloride) AB00053581 AC-10282 AC1L1GGQ AC1Q2Z7J AKOS001026768 ARONIS23855 After Burn Double Strength Gel After Burn Double Strength Spray After Burn Gel After Burn Spray Afterburn Akten Alphacaine Anestacon Anestacon Jelly BIDD:GT0342 BPBio1_000197 BRD-K52662033-001-02-6 BRD-K52662033-003-05-5 BRN 2215784 BSPBio_000179 BSPBio_001359 BSPBio_003004 Bikini Zone Medicated Bikini Zone Medicated Creme Bio-0767 Bio-scriptives Lidum Bio-scriptives Lidum Hemorroidal (anorectal) Bio-scriptives Lidum Topical Analgesic Bio1_000379 Bio1_000868 Bio1_001357 Bio2_000079 Bio2_000559 Burn Relief Leader C07073 C14H22N2O CAS-73-78-9 CDS1_000283 CHEBI:6456 CHEMBL79 CID3676 CPD000058189 Cappicaine Cito optadren Comfortcaine Cuivasil Curacaine Transdermal Corporation D00358 DB00281 Dalcaine Dentipatch Dentipatch (TN) Derma Numb DermaFlex Desert Harvest Releveum Diethylaminoaceto-2,6-xylidide Dilocaine DivK1c_000174 DivK1c_001323 Dr. Numb Dr. Richs Numbing Duncaine EINECS 205-302-8 ELA-Max EMBOLEX Emla Emla Cream Esracaine FT-0082378 Gigi Anesthetic Numbing Gravocain H-releve Hemorrhoidal HMS1791D21 HMS1989D21 HMS2051C21 HMS2089E15 HMS548M19 HSDB 3350 Hawaiian Tropic Hush Anesthetic I01-2704 IDI1_000174 IDI1_033829 Isicaina Isicaine Jetocaine KBio1_000174 KBio2_000079 KBio2_001598 KBio2_002647 KBio2_004166 KBio2_005215 KBio2_006734 KBio3_000157 KBio3_000158 KBio3_002224 KBioGR_000079 KBioGR_000599 KBioSS_000079 KBioSS_001598 L-Caine L0156 L1026_SIGMA L7757_SIGMA LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE) LIDOPEN LQZ LS-805 Lanabiotic | Laryng-o-jet Leostesin Lida-Mantle Lidall Lidocaina Lidocaina [INN-Spanish] Lidocaine Lidocaine (JP15/USP/INN) Lidocaine (VAN) Lidocaine 4% Cream Lidocaine Carbonate Lidocaine Hydrocarbonate Lidocaine Hydrochloride Lidocaine Monohydrochloride Lidocaine [USAN:INN:JAN] Lidocaine hydrochloride Lidocainum Lidocainum [INN-Latin] Lidocare Mist Lidocaton Lidocream 4 Lidocream 5 Lidoderm Lidoderm 5 Lidoject-1 Lidoject-2 Lifestyles Epic Male Genital Desensitizer Lignocaine Lignocainum Lingocaine Lmx4 Lmx5 Lopac-L-5647 Lopac0_000669 MLS000069724 MLS000758263 MLS001074177 Maricaine Maybridge1_002571 MolPort-001-783-478 N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide NCGC00015611-01 NCGC00015611-02 NCGC00015611-03 NCGC00015611-04 NCGC00015611-14 NCGC00022176-05 NCGC00022176-06 NCGC00022176-07 NCGC00022176-08 NCGC00022176-09 NINDS_000174 NSC 40030 NSC40030 Norwood Sunburn Spray Numb Master Topical Anesthetic Numb Nuts Ocean Potion Instant Burn Relief Ice Octocaine Octocaine-100 Octocaine-50 Plum Smooth Plumb Numb Gelee Premjact Male Desensitizer Pound International Prestwick0_000050 Prestwick1_000050 Prestwick2_000050 Prestwick3_000050 Recticare Remicaine Rocephin Kit Rucaina S1357_Selleck SAM001247018 SMR000058189 SPBio_001525 SPBio_002100 STK552033 Simplicity Desensitizing Simply Numb Endure Solarcaine Solarcaine aloe extra burn relief cream Solcain Sole Serum Spectrum2_001343 Spectrum3_001392 Spectrum4_000070 Spectrum5_001549 Spectrum_001118 UNII-98PI200987 WLN: 2N2 & 1VMR B1 F1 Walgreens Aloe Vera Pain Relieving Xilina Xilocaina Xilocaina [Italian] Xllina Xycaine Xylestesin Xylesthesin Xylocain Xylocaine Xylocaine (TN) Xylocaine 5% Spinal Xylocaine CO2 Xylocaine Dental Ointment Xylocaine Endotracheal Xylocaine Test Dose Xylocaine Viscous Xylocaine-Mpf Xylocaine-Mpf with Glucose Xylocaine-mpf Xylocard Xylocitin Xyloneural (free base) Xylotox Zcaine Fast Acting Anesthetic Zilactin-L Zingo alfa-Dietilamino-2,6-dimetilacetanilide alfa-Dietilamino-2,6-dimetilacetanilide [Italian] alpha-Diethylamino-2,6-dimethylacetanilide alpha-diethylamino-2,6-dimethylacetanilide lidocaine nchembio.65-comp16 α-diethylamino-2,6-dimethylacetanilide |
| | 31 | | Sulfacetamide | approved | Phase 4 | 3 | 144-80-9 | 5320 | 127-56-0 (mono-hydrochloride salt, anhydrous) 144-80-9 4-14-00-02662 (Beilstein Handbook Reference) 46770_FLUKA 46770_RIEDEL A-500 AC-7630 AC1L1K3B AI3-26837 AKOS000119729 ARONIS022108 Acetocid Acetosulfamin Acetosulfamine Ak-Sulf Albamine Albucid Alesten BB_SC-5547 BPBio1_000053 BRN 0981718 BSPBio_000047 BSPBio_002773 Bleph-10 Bleph-10 liquifilm CBChromo1_000180 CBDivE_013934 CCRIS 6273 CHEBI:102525 CHEMBL455 CID5320 CPD000058173 Caswell No. 808A Cetamide D05947 DB00634 DivK1c_000227 EINECS 205-640-6 EPA Pesticide Chemical Code 077904 FML-S Formosulfacetamide HMS1921A11 HMS2092I13 HMS500L09 I-Sulfacet I14-13294 IDI1_000227 Isopto cetamide Isopto-Cetamide KBio1_000227 KBio2_001464 KBio2_004032 KBio2_006600 KBio3_001993 KBioGR_001691 KBioSS_001464 Klaron LS-852 MLS000069710 MLS001076499 MolPort-000-900-614 N -Acetylsulfanilamide N'-Acetylsulfanilamide N'-acetylsulfanilamide N(1)-Acetyl-4-aminophenylsulfonamide N(1)-Acetylsulfanilamide N(sup 1)-Acetyl-4-aminophenylsulfonamide N(sup 1)-Acetylsulfanilamide N(sup1)-Acetylsulfanilamide N-((4-Aminophenyl)sulfonyl)acetamide N-((P-Aminophenyl)sulfonyl)acetamide N-((p-Aminophenyl)sulfonyl)acetamide N-(4-Aminobenzenesulfonyl)acetamide N-(4-Aminophenylsulfonyl)acetamide N-(4-aminophenyl)sulfonylacetamide N-(P-Aminobenzenesulfonyl)acetamide N-Acetyl-4-aminobenzenesulfonamide N-Acetylsulfanilamide N-Acetylsulfanilamine N-Sulfanilylacetamide N-Sulphanilylacetamide N-[(4-Aminophenyl)sulfonyl]acetamide N-[(P-Aminophenyl)sulfonyl]acetamide N-[(p-Aminophenyl)sulfonyl]acetamide | N1-Acetylsulfanilamide NCGC00018242-01 NCGC00021857-03 NCGC00021857-04 NCGC00021857-05 NCIOpen2_002838 NINDS_000227 NSC 63871 NSC63871 OP-Sulfa 30 Oclucid Ocusulf-10 Ophthacet Ophthel-S Oprea1_686524 Oprea1_810285 P-Aminobenzenesulfonacetamide P-Aminobenzenesulfonoacetamide Prestwick0_000014 Prestwick1_000014 Prestwick2_000014 Prestwick3_000014 Region S8627_SIGMA SAM002554931 SMR000058173 SPBio_001415 SPBio_001968 SPECTRUM1500545 STK068185 SULSTER Sebizon Sodium sulamyd Sodium sulfacetamide Solfacetamide Solfacetamide [DCIT] Spectrum2_001318 Spectrum3_001017 Spectrum4_001146 Spectrum5_001230 Spectrum_000984 Steramide Steri-Units Sulfacetamide Sulamyd Sulf-10 Sulf-15 Sulfacel-15 Sulfacet Sulfacetamid Sulfacetamida Sulfacetamida [INN-Spanish] Sulfacetamide (USP/INN) Sulfacetamide Monosodium Salt Sulfacetamide Sodium Sulfacetamide Sodium Usp Sulfacetamide [USAN:INN] Sulfacetamide sodium Sulfacetamide sodium anhydrous Sulfacetamidum Sulfacetamidum [INN-Latin] Sulfacetimide Sulfacil Sulfacyl Sulfacyl (VAN) Sulfacylum Sulfacétamide Sulfair Sulfair 15 Sulfair-15 Sulfanilacetamide Sulfanilazetamid Sulfanilazetamid [German] Sulphacetamide Sulphacetamide sodium Sulphacetamidum Sulphasil Sulten-10 Sultrin UNII-4965G3J0F5 Urosulfon Urosulfone WLN: ZR DSWMV1 ZINC00057500 p-Aminobenzenesulfonacetamide p-Aminobenzenesulfonoacetamide sulfacetamide |
| | 32 | | Levofloxacin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 208 | 100986-85-4 | 149096 | (− (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate (-)-Ofloxacin (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (R)-isomer (S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid (S)-(-)-Ofloxacin (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (S)-Ofloxacin )-Ofloxacin 100986-85-4 100986-86-5 28266_FLUKA 28266_SIGMA AC-7593 AC1L3YF8 Aeroquin Ambap100986-85-4 BRD-K09471561-001-06-7 BSPBio_002689 C07660 C18H20FN3O4 C18H20FN3O4.H2O CCRIS 4073 CCRIS 4074 CHEMBL33 CID149096 CPD000466387 Cravit Cravit (TN) Cravit Ophthalmic D08120 DB01137 DR 3354 DR-3355 DR-3355: L-isomer of ofloxacin DR3355 Elequine Floxacin Floxel Floxin HMS1922J07 HMS2051G04 HMS2090O10 HMS2093E18 HR 355 HR-355 Iquix KBio2_002199 KBio2_004767 KBio2_007335 KBio3_001909 KBioGR_001605 | KBioSS_002199 L-Ofloxacin L-ofloxacin L0193 LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER LEVOFLOXACIN LFX LS-133260 LS-171761 LVX Leroxacin Lesacin Levaquin Levofloxacin Levofloxacin (INN) Levofloxacin [USAN:INN:JAN] Levofloxacin hemihydrate Levofloxacin hydrate Levofloxacin tablet, suspension or intravenous Levofloxacine Levofloxacine [INN-French] Levofloxacino Levofloxacino [INN-Spanish] Levofloxacinum Levofloxacinum [INN-Latin] Levokacin Levox Levoxacin MLS000759524 MLS001165709 MLS001423977 MP-376 MolPort-002-885-835 Mosardal NCGC00178529-01 Nofaxin Ofloxacin Ofloxacin S-(-)-form Oftaquix Quixin R-Ofloxacin RWJ 25213-097 RWJ-25213 Reskuin S-(-)-Ofloxacin S1940_Selleck SAM001246758 SMR000466387 SPBio_001891 SPECTRUM1504260 Spectrum2_001676 Spectrum3_000995 Spectrum4_001123 Spectrum5_001438 Spectrum_001719 Tavanic Volequin d-Levofloxacin | |
| | 33 | | Ofloxacin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 208 | 82419-36-1 | 4583 | ( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (+/-)-Floxin 118120-51-7 (hydrochloride) 33703_FLUKA 33703_RIEDEL 8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid 82419-36-1 83380-47-6 85344-55-4 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid AB00513820 AC-7616 AC1L1IHM AKOS001033517 BB_SC-1252 BPBio1_000345 BRD-A24228527-001-05-9 BRN 3657947 BSPBio_000313 BSPBio_003117 Bactocin C07321 C18H20FN3O4 CCRIS 5233 CHEBI:7731 CHEMBL4 CID4583 CPD000058192 D00453 DB01165 DEXTROFLOXACINE DL 8280 DL-8280 DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin Danoflox DivK1c_000721 EU-0100904 Effexin Exocin Exocine FLOXIN IN DEXTROSE 5% FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER Flobacin Flodemex Flotavid Flovid Floxal Floxil Floxin Floxin (TN) Floxin otic Floxstat Fugacin HMS1568P15 HMS1921H12 HMS2090F07 HMS2092B10 HMS502E03 HOE 280 Hoe-280 I06-0112 I06-0380 IDI1_000721 Inoflox KBio1_000721 KBio2_001666 KBio2_004234 KBio2_006802 KBio3_002617 KBioGR_000667 KBioSS_001666 Kinflocin Kinoxacin LS-133259 Liflox Lopac0_000904 Loxinter MLS000028749 MLS001074203 Marfloxacin Medofloxine Mergexin MolPort-000-422-241 MolPort-000-873-068 NCGC00015772-02 NCGC00015772-10 NCGC00094219-01 | NCGC00094219-02 NCGC00094219-03 NCGC00094219-04 NCGC00094219-05 NCGC00094219-06 NCGC00178284-01 NCGC00178284-02 NINDS_000721 NSC727071 Novecin Nufafloqo O 8757 O-Flox O8757_SIGMA OFLX OFX ORF 18489 ORF-28489 Obide Occidal Ocuflox Ofcin Oflin Oflocee Oflocet Oflocin Oflodal Oflodex Oflodura Oflox Ofloxacin Ofloxacin (JP15/USP/INN) Ofloxacin Ophthalmic Ofloxacin Otic Ofloxacin [USAN:BAN:INN:JAN] Ofloxacin, (S)-Isomer Ofloxacina Ofloxacina [DCIT] Ofloxacine Ofloxacine [French] Ofloxacino Ofloxacino [Spanish] Ofloxacinum Ofloxacinum [Latin] Ofloxin Ofus Onexacin Operan Oprea1_242882 Orocin Otonil Oxaldin PT 01 Pharflox Praxin Prestwick0_000237 Prestwick1_000237 Prestwick2_000237 Prestwick3_000237 Puiritol Qinolon Qipro Quinolon Quotavil Rilox Ru-43280 S1463_Selleck SAM002264629 SMR000058192 SPBio_001387 SPBio_002234 SPECTRUM1502044 STK256723 Sinflo Spectrum2_001464 Spectrum3_001499 Spectrum4_000324 Spectrum5_001063 Spectrum_001186 Tabrin Taravid Tariflox Tarivid Telbit Tructum UNII-A4P49JAZ9H Uro Tarivid Viotisone Visiren WP-0405 XED Zanocin ofloxacin |
| | 34 | | Epinastine | approved, investigational | Phase 4, Phase 3 | 19 | 80012-43-7 | 3241 | (+-)-Epinastine 108929-04-0 (hydrochloride) 134507-59-8 3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine 3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine 3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine 80012-43-7 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine AC-15948 AC1L1FHQ C16H15N3 CHEBI:51032 CHEMBL1106 CID3241 D07900 DB00751 Elestat Epinastin Epinastina Epinastina [Spanish] | Epinastine Epinastine (INN) Epinastine Hydrochloride Epinastine [INN] Epinastinum Epinastinum [Latin] I06-0349 L000716 LS-177526 MolPort-005-935-541 NCGC00165791-01 NCGC00165791-02 NCGC00165791-03 Purivist Purivist (TN) SBB066107 UNII-Q13WX941EF WAL 80 WAL 801 WAL 801CL WAL-80 Cl epinastine |
| | 35 | | Histamine Phosphate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 906 | 51-74-1 | 65513 | 1H-Imidazole-4-ethanamine, phosphate (1:2) 2-Imidazol-4-ylethylamine orthophosphoric acid (1:2) 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate) 4-(2-Aminoethyl)imidazole di-acid phosphate 4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate 51-74-1 53623-99-7 74-56-6 AC1L23E4 CID65513 D04445 DB00667 EINECS 200-118-4 | H0147 Histamine Positive Skin Test Control Histamine Positive skin test control Histamine acid phosphate Histamine biphosphate Histamine dihydrogen phosphate Histamine diphosphate Histamine phosphate (1:2) Histamine phosphate (TN) Histamine phosphate (USP) Histamine phosphate [USP] Histamine positive Histaminum LS-78569 UNII-QWB37T4WZZ |
| | 36 | | Dopamine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 3084 | 62-31-7, 51-61-6 | 681 | (3H)-Dopamine .Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium 153C5321-5FEE-4B0B-8925-F388F0EEEBD1 2-(3,4-Dihydroxyphenyl)ethylamine 2-(3,4-dihydroxyphenyl)ethylamine 2-benzenediol 3,4-Dihydroxyphenethylamine 3,4-Dihydroxyphenethylamine hydrochloride 3,4-Dihydroxyphenylethylamine 3,4-dihydroxyphenethylamine 3-Hydroxtyramine 3-Hydroxytyramine 3-Hydroxytyramine Hydrobromide 3-Hydroxytyramine hydrochloride 4-(2-Aminoethyl)-1, 4-(2-Aminoethyl)-1,2-benzenediol 4-(2-Aminoethyl)-1,2-bezenediol 4-(2-Aminoethyl)-Pyrocatechol 4-(2-Aminoethyl)benzene-1,2-diol 4-(2-Aminoethyl)catechol 4-(2-Aminoethyl)pyrocatechol 4-(2-Aminoethyl)pyrocatechol hydrochloride 4-(2-aminoethyl)-pyrocatechol 50444-17-2 51-61-6 62-31-7 (HYDROCHLORIDE) AC1L19S5 AC1Q54AX AC1Q54AY AKOS003790978 ASL 279 BIDD:ER0506 BPBio1_001123 BSPBio_001932 Biomol-NT_000001 C03758 CHEBI:18243 CHEMBL59 CID681 D07870 DB00988 Deoxyepinephrine DivK1c_000780 Dopamin Dopamina Dopamina [INN-Spanish] Dopamine Dopamine (INN) Dopamine (USAN)(*hydrochloride*) Dopamine Hcl Dopamine Hydrochloride Dopamine [INN:BAN] Dopaminum Dopaminum [INN-Latin] Dopastat Dophamine Dynatra EINECS 200-110-0 HSDB 3068 Hydroxytyramin Hydroxytyramine IDI1_000780 IP 498 Intropin Intropin [*hydrochloride*] | KBio1_000780 KBio2_001492 KBio2_002388 KBio2_002484 KBio2_004060 KBio2_004956 KBio2_005052 KBio2_006628 KBio2_007524 KBio2_007620 KBio3_001152 KBio3_002867 KBio3_002962 KBioGR_001129 KBioGR_002388 KBioGR_002484 KBioSS_001492 KBioSS_002393 KBioSS_002491 KW-3-060 L-DOPAMINE L000232 LDP LS-159 Lopac-H-8502 Lopac0_000586 Medopa (TN) MolPort-001-641-000 NCGC00015519-01 NCGC00015519-08 NCGC00096050-01 NCGC00096050-02 NCGC00096050-03 NCGC00096050-04 NCGC00096050-05 NINDS_000780 NSC 173182 NSC169105 NSC173182 Oprea1_088821 Oxytyramine Pyrocatechol, 4-(2-aminoethyl)- (8CI) Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride Revimine Revivan SPBio_001205 SPECTRUM1505155 ST048774 STK301601 Spectrum2_001023 Spectrum3_000406 Spectrum4_000525 Spectrum5_000945 Spectrum_001012 UNII-VTD58H1Z2X UPCMLD0ENAT5885989:001 a-(3,4-Dihydroxyphenyl)-b-aminoethane alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane cMAP_000036 cMAP_000065 dopamine hydroxytyramine intropin m-Hydroxytyramine hydrochloride nchembio.105-comp9 nchembio.107-comp4 nchembio.284-comp1 nchembio.78-comp16 nchembio.89-comp3 nchembio705-8 nchembio801-comp8 |
| | 37 | | Levodopa | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 363 | 59-92-7 | 6047 | (-)-(3,4-Dihydroxyphenyl)alanine (-)-3-(3,4-Dihydroxyphenyl)-L-alanine (-)-3-(3,4-dihydroxyphenyl)-L-alanine (-)-Dopa (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid (−)-3-(3,4-dihydroxyphenyl)-L-alanine (−)-dopa .Beta.-(3, 4-Dihydroxyphenyl)alanine .Beta.-(3,4-Dihydroxyphenyl)-L-alanine 1E83F927-C221-46AA-B90A-81B33C5F3868 2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid 23734-74-9 25525-15-9 3, 4-Dihydroxy-L-phenylalanine 3, 4-Dihydroxyphenylalanine 3,4-DIHYDROXYPHENYLALANINE 3,4-Dihydroxy-L-phenylalanine 3,4-Dihydroxyphenyl-L-alanine 3,4-Dihydroxyphenylalanine 3,4-Dihydroxyphenylalanine (VAN) 3,4-dihydroxy-L-phenylalanine 3,4-dihydroxyphenylalanine 3-(3,4-Dihydroxypheny 3-(3,4-Dihydroxyphenyl)-L-alanine 3-Hydroxy-L-tyrosine 34241-25-3 37830_FLUKA 587-45-1 59-92-7 72572-99-7 72573-00-3 88250-23-1 90638-38-3 AC-11686 AC1L1LOR AC1Q4U7F BIDD:GT0158 BPBio1_000059 BSPBio_000053 BSPBio_002354 Bendopa Bio-0575 Biodopa Brocadopa C00355 C9H11NO4 CAS-59-92-7 CCRIS 3766 CHEBI:15765 CHEMBL1009 CID6047 Cerepap Cidandopa D 9628 D00059 D0600 D9628 D9628_SIGMA DAH DB01235 DOPA Deadopa Dihydroxy-L-phenylalanine Dihydroxyphenylalanine DivK1c_000452 Dopa Dopaflex Dopaidan Dopal Dopal-Fher Dopal-fher Dopalina Dopar Dopar (TN) Doparkine Doparl Dopasol Dopaston Dopaston SE Dopastone Dopastral Dopicar Doprin EINECS 200-445-2 EU-0100454 Eldopal Eldopar Eldopatec Eurodopa HMS1568C15 HMS1922J14 HMS2090O08 HMS2093N04 HMS501G14 HSDB 3348 Helfo DOPA | Helfo-Dopa Helfo-dopa IDI1_000452 IV Levodopa InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14 Insulamina KBio1_000452 KBio2_000934 KBio2_003502 KBio2_006070 KBioGR_001177 KBioSS_000934 L Dopa L(-)-Dopa L-(-)-Dopa L-(3, 4-Dihydroxyphenyl)-.alpha.-alani L-(3, 4-Dihydroxyphenyl)alanine L-(o-Dihydroxyphenyl)alanine L-.Beta.-(3,4-Dihydroxyphenyl)alanine L-3,4-Dihydroxyphenylalanine L-3,4-dihydroxyphenylalanine L-3-(3,4-Dihydroxyphenyl)-Alanine L-3-(3,4-Dihydroxyphenyl)alanine L-3-Hydroxytyrosine L-4-5-Dihydroxyphenylalanine L-DOPA L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa L-Dihydroxyphenylalanine L-Dopa L-O-Dihydroxyphenylalanine L-b-(3,4-Dihydroxyphenyl)-a-alanine L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine L-beta-(3,4-Dihydroxyphenyl)alanine L-o-Hydroxytyrosine LS-255 Laradopa Larodopa Ledopa Levedopa Levodopa Levodopa (JP15/USP) Levodopa (JP15/USP/INN) Levodopa [USAN:INN:BAN:JAN] Levodopum Levodopum [INN-Latin] Levopa Lopac-D-9628 Lopac0_000454 MLS000028514 Maipedopa MolPort-000-856-937 NCGC00015384-01 NCGC00016270-01 NCGC00016270-06 NCGC00093869-04 NINDS_000452 NSC 118381 NSC118381 PDSP1_001541 PDSP2_001525 Parda Pardopa Prestwick0_000017 Prestwick1_000017 Prestwick2_000017 Prestwick3_000017 Prestwick_185 Prodopa Ro 4-6316 S1726_Selleck SDCCGMLS-0066924.P001 SMR000058312 SPBio_000391 SPBio_001974 SPECTRUM2300205 Sobiodopa Spectrum2_000496 Spectrum4_000539 Spectrum5_001899 Spectrum_000454 Syndopa UNII-46627O600J Veldopa Weldopa b-(3,4-Dihydroxyphenyl)-L-alanine b-(3,4-Dihydroxyphenyl)-a-L-alanine b-(3,4-Dihydroxyphenyl)alanine beta-(3,4-Dihydroxyphenyl)-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-alanine beta-(3,4-Dihydroxyphenyl)alanine bmse000322 component of Sinemet l)-L-alanine nchembio.2007.55-comp26 nchembio.89-comp9 ne β-(3,4-dihydroxyphenyl)alanine | |
| | 38 | | Dalfampridine | approved | Phase 4, Phase 2, Phase 3 | 62 | 504-24-5 | 1727 | .gamma.-Aminopyridine 275875_ALDRICH 36687_FLUKA 36687_RIEDEL 4 AP 4 Aminopyridine 4 Aminopyridine Sustained Release 4-AP 4-Aminopyridine 4-Aminopyridine 10 4-Aminopyridine Sustained Release 4-Pyridinamine 4-Pyridylamine 4-aminopyridine 5-22-09-00106 (Beilstein Handbook Reference) 504-24-5 A 0152 A0414 A78403_ALDRICH AB1004971 AC-907/25014071 AC1L1C3R AC1Q52BM AI3-52547 AKOS000119896 Amaya Amino-4 pyridine Amino-4-Pyridine Ampydin Ampyra Avitrol Avitrol 200 BB_SC-6974 BRN 0105782 BSPBio_001562 Bio1_000353 Bio1_000842 Bio1_001331 Bio2_000282 Bio2_000762 C13728 C5H6N2 CHEBI:34385 CHEMBL284348 CID1727 Caswell No. 038 Compound 1861 D015761 D04127 Dalfampridine DivK1c_000572 EINECS 207-987-9 EL-970 EPA Pesticide Chemical Code 069201 EU-0100032 FT-0083754 Fampridina Fampridine Fampridine (USAN/INN) Fampridine SR Fampridine [USAN:INN] Fampridine-PR Fampridine-SR Fampridinum Fampyra HC150041 HMS1361O04 HMS1791O04 HMS1921H15 HMS1989O04 HMS2092F05 HMS501M14 HSDB 6037 IDI1_000572 IDI1_034032 InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7 | KBio1_000572 KBio2_000282 KBio2_000635 KBio2_002850 KBio2_003203 KBio2_005418 KBio2_005771 KBio3_000563 KBio3_000564 KBio3_001888 KBioGR_000282 KBioGR_001505 KBioSS_000282 KBioSS_000635 LS-130202 Lopac-A-0152 Lopac0_000032 MLS000069400 Mi-W-3 MolPort-000-146-022 N07XX07 NCGC00015009-01 NCGC00015009-03 NCGC00015009-12 NCGC00024890-01 NCGC00024890-02 NCGC00024890-03 NCGC00024890-04 NCGC00024890-05 NCGC00024890-06 NCGC00024890-07 NCGC00024890-08 NCGC00024890-09 NCGC00024890-10 NINDS_000572 NSC 15041 NSC15041 Neurelan Neurelan (TN) P-Aminopyridine PYRIDINE,4-AMINO Philips 1861 Phillips 1861 Pimadin (free base) Prc 1237 Pymadin Pymadine RCRA waste no. P008 SDCCGMLS-0066228.P001 SMR000058211 SPBio_001486 SPECTRUM1501130 STK298717 Spectrum2_001413 Spectrum3_000914 Spectrum4_001013 Spectrum5_001501 Spectrum_000155 Sustained Release, 4-Aminopyridine TL8003344 Tocris-0940 UNII-BH3B64OKL9 UPCMLD-DP125 UPCMLD-DP125:001 VMI 10-3 VMI 103 VMI-10-3 VMI-103 VMI103 WLN: T6NJ DZ [J.Pharmacol.Exp.Ther. 275:864 (1995)] gamma-Aminopyridine nchem.892-comp4 p-Aminopyridine p-Aminopyridine [UN2671] [Poison] p-Aminopyridine [UN2671] [Poison] pyridin-4-amine pyridin-4-ylamine |
| | 39 | | Verteporfin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 83 | 129497-78-5 | 5362420 | | Verteporfinum Vertéporfine Visudyne | |
| | 40 | | Carbidopa | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 159 | 28860-95-9 | 34359, 38101 | (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1) (AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate (S)-(-)-Carbidopa hydrate (S)-(-)-carbidopa (S)-(-)-carbidopa hydrate (S)-(−)-carbidopa hydrate (S)-alpha--Hydrazino-3,4-dihydroxy-alpha--methyl-benzenepropanoic acid monohydrate (S)-carbidopa (S)-carbidopa hydrate (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate 27925-91-3 28860-95-9 31823-41-3 38821-49-7 AC-1676 AC1L1RFR AC1L1Z32 AC1Q5QGW Atamet BB_SC-5095 Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S) C-126 C-DOPA C126_SIGMA C1335_SIGMA CCRIS 5093 CHEBI:3395 CHEBI:39585 CHEMBL1200748 CHEMBL1201236 CID34359 CID38101 CPD-11550 Carbidopa Carbidopa (anhydrous) Carbidopa Anhydrous Carbidopa Monohydrate Carbidopa [USAN:INN:BAN] Carbidopa anhydrous Carbidopa hydrate Carbidopa monohydrate Carbidopa, (S)-Isomer | Carbidopa, Entacapone, & Levodopa Carbidopa-1-wasser Carbidopum Carbidopum [INN-Latin] Carbidopum monohydricum DB00190 EINECS 249-271-9 EU-0100382 HMS2089B12 Hadrazino-alpha-methyldopa Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid L-alpha-(3,4-Dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid L-alpha-Methyldopahydrazine LS-77199 Lodosin Lodosyn Lodosyn, Carbidopa Lopac0_000382 MK 486 MK-485 MK-486 MLS000069628 MLS002207014 Methyldopahydrazine MolPort-003-940-629 MolPort-005-934-181 N-Aminomethyldopa NCGC00024596-01 NCGC00024596-03 NCGC00024596-05 NCGC00024596-06 S(-)-CARBIDOPA S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate S-(-)-Carbidopa S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid S1891_Selleck SMP1_000057 SMR000058235 ST055523 Stalevo Tocris-0455 UNII-KR87B45RGH UNII-MNX7R8C5VO alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid alpha-Methyldopahydrazine carbidopa carbidopa hydrate carbidopum monohydricum |
| | 41 | | Norgestimate | approved | Phase 4, Phase 3, Phase 2 | 351 | 35189-28-7 | 6540478 | (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester) (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime (17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime (3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate 35189-28-7 AC-655 AC1O712U C017576 CHEBI:50815 CHEMBL1200934 CID6540478 D 138 D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime D05209 DB00957 Dexnorgestrel Acetime Dexnorgestrel acetime I14-9729 | LS-62080 NCGC00181353-01 NORGESTIMATE Norgestimate (USP/INN) Norgestimate [USAN:INN:BAN] Norgestimato Norgestimato [INN-Spanish] Norgestimatum Norgestimatum [INN-Latin] ORF 10131 ORF-10131 Ortho-Prefest RWJ 10131 RWJ-10131 UNII-C291HFX4DY ZINC03938695 [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime d-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime norgestrel oxime acetate |
| | 42 | | Menthol | approved | Phase 4, Phase 3, Phase 2, Phase 0 | 1999 | 2216-51-5 | 16666 | (− ()-Menthol (+)-Neo-menthol (+)-p-Menthan-3-ol (+-)-(1R*,3R*,4S*)-Menthol (+-)-Menthol (+/-)-Menthol (+/-)-p-Menthan-3-ol (-)-(1R,3R,4S)-Menthol (-)-Menthyl alcohol (-)-menthol (-)-p-Menthan-3-ol (-)-trans-p-Menthan-cis-ol (1R)-(-)-Menthol (1R,2S,5R)-(-)-menthol (1R,2S,5R)-Menthol (1R,3R,4S)-(-)-MENTHOL (1R,3R,4S)-(-)-Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol (1S, 2S, 5R)-(+)-Neomenthol (1S,2R,5R)-(+)-Isomenthol (1S,2R,5S)-(+)-Menthol (1S,2R,5S)-Menthol (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol (1r,2s,5r)-(-)-menthol (L)-MENTHOL (R)-(-)-Menthol (r)-(-)-menthol )-Menthol --MENTHOL 1-Menthol 1490-04-6 15356-60-2 15356-70-4 15785_RIEDEL 15785_SIAL 19863P 2-Isopropyl-5-methylcyclohexanol 20747-49-3 2216-51-5 3-p-Menthol 4-Isopropyl-1-methylcyclohexan-3-ol 491-02-1 5-Methyl-2-(1-methylethyl)-cyclohexanol 5-Methyl-2-(1-methylethyl)cyclohexanol 5-methyl-2-(propan-2-yl)cyclohexanol 5-methyl-2-propan-2-ylcyclohexan-1-ol 551376_ALDRICH 551376_FLUKA 588733_ALDRICH 613290_ALDRICH 613290_FLUKA 63660_FLUKA 63670_ALDRICH 63670_FLUKA 63975-60-0 6C6A4A8C-A054-468C-A1F0-F29E39838CF2 89-78-1 98167-53-4 999 Itch Relief AC1L1B2E AC1L28FR AC1Q1NQ2 AC1Q2QQM AI3-08161 AI3-52408 AKOS000119740 AR-1J3337 Absorbine Back Therapeutic Pain Relief Absorbine Jr Absorbine Jr Ultra Strength Pain Relieving Absorbine Jr. Absorbine Jr. Back Algomend Pain Relief Alhua Huogan Pain Relieving Patch Aloemint Skin Aid Amar Ice Analgesic Anc Neverpain External Analgesic Anti Itch Army Health Pain Reliever Arthri-support Arthri-zen Relief Arthripain Relief Arthritis Relief Aspercreme Heat Aspercreme Max No Mess Roll On Assured Cold N Hot Pain Relief Menthol Assured Extra Strength Cold N Hot Assured Ice Cold Topical Analgesic Assured Muscle Rub Assured Pain Relief Hot Menthol Atopalm Pain Relieving Aurorae Healing Pain Relieving Roll-on Avapta Avedana Pain Relieving Roll On Avedana Pain-relieving BB_NC-0057 BRN 1902288 BRN 3194263 BSPBio_003062 Babyganics Cold Relief Chest Rub Barox Barox BODY CARE MASSAGE Barox Body Care Massage Relax Refresh Revital Being Well Extra Strength Menthol Heat Bengay Ultra Strength Large Size Bengay Ultra Strength Pain Relieving Large Size Bengay Ultra Strength Pain Relieving Regular Size Bengay Ultra Strength Regular Size Bengay Vanishing Scent Bengay Zero Degrees Menthol Pain Relieving Bentasil SUGAR FREE BLACKCURRANT SOFT Texture Bentasil SUGAR FREE CHERRY SOFT Texture Bentasil SUGAR FREE HONEY LEMON SOFT Texture Berri-freez Besthealth Cherry Besthealth Cough Suppressant Sugar Free Black Cherry Flavor Besthealth Cough Suppressant Sugar Free Honey Lemon Flavor Besthealth Honey Lemon Besthealth Menthol Bio 2 Brazilian Heat Brazilian Heat Bio-scriptives Extreme Pr Bioblast Pain Relief Bioflexor Biofreeze Biofreeze Colorless Biofreeze Colorless Roll-on Biofreeze Roll-on Biorelief Ice Pain Relieving Blistex Ivarest Medicated Poison Ivy Cleansing Foam Blue Gel Pain Relieving Blue Ice Blue Ice Analgesic Blue Ice Analgesic Gel Blue Ice Pain Relieving Body Budpack Muscle Rub Budpak Muscle Rub C00400 C10H20O CCRIS 3728 CCRIS 375 CCRIS 4666 CCRIS 9231 CHEBI:15409 CHEBI:545611 CHEMBL256087 CHEMBL470670 CID1254 CID16666 Canker Complete Canker Sore Relief Caswell No. 540 Celadrin Cepacol Sore Throat From Post Nasal Drip Cepacol Sore Throat Regular Strength Ching Wan Hung Soothing Herbal Balm Choice Personal Care Theraputic Blue Ice Cold Hot Patch Cold Spot Point Relief Coldaid Cool N Heat Patch For Back Extra Strength Coralite Extra Strength Menthol Pain Relief Sleeve - Knee Coralite Extra Strength Menthol Pain Relief Sleeve - Wrist Coralite Pain Relief Counteract Cough Drops Honey Lemon Counteract Cough Drops Orchard Cherry Cryogel Island Rain Natural Pain Relieving Vitaminerals Cvs Cold Hot Medicated Cvs Soothing Itch Relief Cvs Sore Muscle Rub Vanishing Scent Cvs Therapeutic Menthol Gel Cvs Therapeutic Menthol Pain Reliever Cvs Tropical Citrus Cough Cvs Ultra Strength Pain Relieving Cvs Vanishing Scent Muscle Rub D-(-)-Menthol D-p-Menthan-3-ol D00064 D008610 D04849 D04918 DB00825 Dg Health Extra Strength Medicated Dg Health Pain Relieving Dg Ice Cold Analgesic Diapedic Foot Treatment DivK1c_000820 Dorflex Icy Hot Flexible, Large Dorflex Icy Hot Flexible, Small Dorflex Icy Hot Flexible, XL Dr. Blue Dt Ice Cold Analgesic Dual Action Cherry Cough Suppressant Oral Anesthetic Dynafreeze EINECS 201-939-0 EINECS 207-724-8 EINECS 216-074-4 EINECS 218-690-9 EINECS 239-387-8 EINECS 239-388-3 EPA Pesticide Chemical Code 051601 Easy Eb301ap Pain Relief Eb301ct Bruise Pain Relief Eb302 Arthritis Relief Ecolyptus Pain Relieving Muscle Rub Efac Pain Relieving Elgin Pain Relief Equaline Blue Ice Pain Relieving Equate Menthol Extra Strength Eros Iron Man Eucalyptamint Eucerin Calming Itch Relief Treatment Extra Strength Cold N Hot Pain Relief Medicated Extra Strength Pain Relief Therapy Extra Strength Stopain Cold Pain Relieving Extra Strength Stopain Cold Pain Relieving Roll On FEMA No. 2665 Family Care Maximum Strength Medicated Anti Itch Fast Freeze Fisherman's friend lozenges Fisherman's friend lozenges (TN) Flexall Pain Relieving Flexgen Fluaid Foot Works Achy Foot Massager Pain Relieving Gold Bond Foot Extra Strength Gold Bond Medicated Foot Gold Bond Pain Relieving Foot Gold Bond Pain Relieving Foot Roll On Green Bamboo Green Guard Cough Drop Relief HMS1922G13 HMS2092L14 HMS502I22 HSDB 5662 HSDB 593 Halls Apple Cider Halls Butterscotch Halls Cherry Halls Extra Strong Menthol Halls Honey Lemon Halls Ice Peppermint Halls MENTHO-LYPTUS Halls Melon Splash Halls Menthol Halls Mentholyptus Halls Mocha Mint Halls Naturals Honey Lemon Chamomile Halls Plus Cherry Halls Plus Honey Halls Plus Strawberry Halls Spearmint Halls Strawberry Halls Sugar Free Black Cherry Halls Sugar Free Citrus Blend Halls Sugar Free Extra Strong Menthol Halls Sugar Free Honey Berry Halls Sugar Free Honey Lemon Halls Sugar Free Mountain Menthol Halls Tropical Fruit Hallsmelon Splash Melon Splash Hallssugar Free Extra Sugar Free Extra Strong Menthol Han Honey Loquat Syrup Hanbang Cataplasma Harmon Extra Strength Pain Relieving Harmon Extra Strength Pain Relieving Roll-on Headache crystals Health Smart Medicated Foot Herbion Naturals Honey Lemon Herbion Naturals Honey Lemon Cough Drops Herbion Naturals Honey-Lemon Cough Drops Herbion Naturals Mint Cough Drops Herbion Naturals Orange Herbion Naturals Orange Cough Drops Hexahydrothymol Hielo Ardiente Honibe | Hot Ice Soothing Analgesic Gel Huitomi Slimming Sports Humphreys Bendito Alcoholado I06-1216 I14-7371 IDI1_000820 Ice Ice Cold Analgesic Ice Cold Topical Analgesic Gel Ice External Analgesic Leader Ice Quake Ice Quake Muscle Rub Icy Cool Maximum Strength Icy Hot Icy Hot Back Icy Hot Medicated Icy Hot Medicated No Mess Applicator Icy Hot Medicated Roll Large Icy Hot Medicated Roll Medium Icy Hot Medicated Roll, Large Icy Hot Medicated Roll, Medium Icy Hot Medicated, Advanced Relief Icy Hot Medicated, Back Icy Hot Medicated, XL Icy Hot Naturals Icy Hot Power Gel Icy Hot Vanishing Scent Icyhot Medicated Imada Four Seasons Safe Analgesic Balm Jakemans Blueberry Jakemans Cherry Jakemans Peppermint K2 Cold Therapy KBio1_000820 KBio2_000785 KBio2_003353 KBio2_005921 KBio3_002562 KBioSS_000785 Kay Medic Menthol Pain Relief Kool Comfort Kool Comfort Pain Relieving Roll-on Kpp Triple Action L-(-)-Menthol L-(-)-menthol L-Menthol L-menthol LMPR0102090001 LS-2353 LS-57201 LS-886 LS-89531 LS-89533 La Jiao Feng Shi Gao Lander Polar Ice Leader Cough Drops Cherry Flavor Leader Cough Drops Honey Lemon Leader Cough Drops Menthol Flavor Leader Extra Strength Medicated Pain Relief Patch Leader Sugar Free Cough Drops Black Cherry Levomenthol Levomenthol [INN:BAN] Levomentholum Levomentholum [INN-Latin] Levomentol Linkus Lozenges Cough Suppressant/Oral Anesthetic Low Sugar Cherry Flavor Fishermans Friend Menthol Cough Suppressant Ludens Honey Lemon Throat Drops Ludens Honey Licorice Throat Drops Ludens Original Menthol Throat Drops Lurosil M0321 M0545 M2772_SIAL MENTHOL MLS002207256 Makesense Extra Strength Muscle Rub Maxfit Freeze Gel Maybelline New York Baby Lips Dr Rescue Medicated Balm Medi First Plus Cherry Cough Drops Medi-first Cherry Cough Drops Medic Ice Medicated Body Powder Medicated Pain Relief Mediflex Medique Medikoff Drops Medique Sugar Free Medikoff Drops Meditowel PAIN RELIEF Meijer Cherry Cough Drops Meijer Honey Lemon Cough Drops Meijer Menthol Cough Drops Menthacamphor Menthol Menthol (USP) Menthol (VAN) Menthol Fresh Cough Suppressant Menthol natural Menthol natural, brazilian Menthol racemic Menthol racemique Menthol racemique [French] Menthol solution Menthol, (1alpha,2beta,5alpha)-Isomer Mentholatum Pain Relief Extra Strength Mentholatum Sports Pain Relief Cold Menthomenthol Menthyl alcohol Mineral Ice Pain Relieving Miracle Foot Repair Miracle Foot Repair Cream Miracle Of Aloe Rub Roll On Miracle Pain Cream Moisture Therapy Anti-Itch MolPort-000-849-729 MolPort-001-793-392 Moore Medical Cherry Cough Suppressant/anesthetic Drops Moore Medical Sugar Free Black Cherry Cough Suppressant/anesthetic Drops Moore Medical Sugar Free Menthol Cough Suppressant/anesthetic Drops Mr Dudleys Topical Pain Relief Muscle Muscle Rub Ultra Strength Pain Relieving Myo-breathe Myorx Low Dose Pain Relieving Myorx Pain Relieving NCGC00159382-02 NCGC00159382-03 NCGC00164247-01 NCGC00164247-02 NCI-C50000 NINDS_000820 NOOLISFMXDJSKH-KXUCPTDWBX NSC 2603 NSC 62788 NSC2603 NSC62788 Nan San Easy Flex Pain Relieving Natural Cherry Honey Herb Throat Drops Natural Herb cough drop Natural Honey Herb Cough Suppressant Throat Drops Natural Lemon Mint Herb Throat Drops Natural Pain Relieving Lavender Breeze Cryogel Natures Choice Cool Hot Ice Natures Sunshine Products Everflex Topical Analgesic Pain Relief Neoisomenthol Nice Assorted Nice Cherry Nice Citrus Nice Cool Mint Nice Honey Lemon Nice Menthol No Pain More Gain North Cough Drop Numotizine Olbas Lozenges Maximun Strength Olbas Pastilles Original Extra Strong All Natural Fishermans Friend Menthol Cough Suppressant Ortho-nesic Osmoflex Oxyrub Pain Relief Pain Relief Balmpreferred Plus Ph Preferred Plus Pharmacy Pain Relief Therapy Patch Pain Reliever Pain Relieving Pain Relieving Analgesic Pain Relieving Patch Pain Relieving Patch Ultra Strength Pain Relieving Patch Ultra Strength ULTRA STRENGTH Panitrol XR Paraid Extra Strength Menthol Pain Relief Sleeve Knee Large Ankles Elbows Patch Scherer Labs Patch Walgreens Peppermint camphor Perfect Purity Hotice Perfect Purity Medicated Foot Powder Perform Personal Care Extra Strength Cold Hot Personal Care Ice Cold Plaster MandAHerbalPlaster Po Sum On Medicated Polar Frost Cold Power Relief Preferred Plus Body Powder Premier Value Medicated Foot Powder Q Health Pain Relief Spray Quickflex RACEMIC MENTHOL U.S.P. Racementhol Racementhol [INN:BAN] Racementholum Racementholum [INN-Latin] Racementol Racementol [INN-Spanish] Racemic menthol Raw Heat Raw Ice Reactice Reactivating Ice Baume Red Lion Relief Relief Pain Relieving Cream Rexall Vanishing Scent Pain Relieving Robitussin Cough Drops SDCCGMLS-0066659.P001 SMR001306785 SPBio_000869 SPECTRUM1503134 STK802468 Screamin Menthol Toast Sella Natural Skin So Soft Bug Guard Plusitch Relief itch relief Smith Bros Honey Lemon Cough Drops Smith Bros Menthol Eucalyptus Cough Drops Smith Bros Sugar-free Black Cherry Cough Drops Sof Skin Icy Blue Sofskin Ice Analgesic Sombra Cool Therapy Spectrum2_000855 Spectrum3_001561 Spectrum5_001060 Spectrum_000305 Stopain Cold Pain Relieving Stopain Cold Professional Strength Pain Relieving Stopain Extra Strength Pain Relieving Sub-zero COOL PAIN RELIEVING Sugar Free Cherry Fishermans Friend Menthol Cough Suppressant Sugar Free Cherry Herb Throat Drops Sugar Free Lemon Mint Herb Throat Drops Sugar Free Mountain Herb Cough Suppressant Throat Drops Sugar Free Original Swiss Herb Cough Suppressant Throat Drops Sugar Free Refreshing Mint Fishermans Friend Menthol Cough Suppressant Sugar Free Swiss Cherry Herb Throat Drops The Medicine Shoppe Extra Strength Pain Relieving The Original Natural Herb Cough Drops Therafreeze Theraid Therapeutic Relief Preferred Plus Pharmacy Theraplus Plus Throat Coat Tianhe Guben Yaoshen Tie Gao Top Care Medicated Topcare Medicated Tra-kill tracheal mite killer U.S.P. Menthol U.S.p. Menthol UNII-BZ1R15MTK7 UNII-L7T10EIP3A UNII-YS08XHA860 Ultra Strength Stopain Pain Relieving Us Favorite Cold Pain Relieving Vaporizing Colds Rub Vicks Vapodrops Cough Relief Vitaminerals Inc. Cryogel Natural Pain Relieving W266507_ALDRICH W266523_ALDRICH W266590_ALDRICH WLN: L6TJ AY1&1 BQ D1 WLN: L6TJ AY1&1 DQ D1 -L Walgreens Aloe Vera Cooling Watermelon Frost Sore Throat Wellpatch Backache Pain Relief Xtracare Ice Cold Topical Analgesic Gel Youngevity Invision CM Yun Xiang Jing ZINC01482164 Zhong Hua Jiu Patch Zims Arnica Max cis-1 ,3-trans-1,4-(+-)-menthol cis-1,3-trans-1,4-(+-)-menthol d,l-Menthol d-Menthol d-Neomenthol dl-3-p-Menthanol dl-Menthol dl-Menthol (JP15) l-(-)-Menthol l-Menthol l-Menthol (JP15) l-Menthol (TN) l-Menthol (natural) nchembio862-comp1 p-Menthan-3-ol rac-Menthol | |
| | 43 | | Estradiol | approved, investigational | Phase 4, Phase 3, Phase 2 | 1094 | 50-28-2 | 5757, 53477783 | (+)-3,17b-Estradiol (17b)-Estra-1,3,5(10)-triene-3,17-diol (17beta)-Estra-1,3,5(10)-triene-3,17-diol .alpha.-Estradiol .alpha.-Oestradiol .beta.-Estradiol .beta.-Oestradiol 1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate 1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol 17 beta-Estradiol 17-.BETA.-Estradiol 17-E 17-beta 17-beta-OH-estradiol 17-beta-estradiol 17.beta.-Estradiol 17.beta.-Oestradiol 17E 17b-Estradiol 17b-Oestradiol 17beta Oestradiol 17beta oestradiol 17beta-Estra-1,3,5(10)-triene-3,17-diol 17beta-Estradiol 17beta-Oestradiol 1jgl 1qkt 1qku 2d06 3,17-Epidihydroxyestratriene 3,17-beta-Estradiol 3,17-beta-Oestradiol 3,17.beta.-Estradiol 3,17b-Dihydroxyestra-1,3,5(10)-triene 3,17b-Estradiol 3,17beta-Estradiol 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate 50-28-2 73459-61-7 873662-39-6 AC-10460 AC1L1L2K Aerodiol Agofollin Alora Altrad Amnestrogen Aquadiol B-Estradiol BEDOs BIDD:ER0125 BIDD:PXR0065 BPBio1_000532 BSPBio_000482 BSPBio_001065 Bardiol Benzhormovarine Beta-estradiol Bio-0812 Bio-E-Gel Bio1_000403 Bio1_000892 Bio1_001381 Bio2_000363 Bio2_000843 C00951 C18H24O2 CCRIS 280 CHEBI:16469 CHEMBL135 CID5757 CMC_11154 CPD-352 CPD000059126 Climaderm Climara Climara (TN) Climara Forte Compudose Compudose 200 Compudose 365 Corpagen D-3,17beta-Estradiol D-Estradiol D-Oestradiol D00105 DB00783 Depo-estradiol Dermestril Destradiol Dihydro-Theelin Dihydrofollicular hormone Dihydrofolliculin Dihydromenformon Dihydrotheelin Dihydroxyesterin Dihydroxyestrin Dihydroxyoestrin Dimenformon Diogyn Diogynets Divigel Divigel (TN) E 2 E 8875 E(sub 2) E0025 E1024_SIGMA E1132_SIGMA E2257_SIGMA E2758_SIGMA E8875_SIGMA EINECS 200-023-8 EU-0100503 Elestrin Encore Epiestriol 50 Esclim Estra-1,3,5(10)-triene-3,17b-diol Estrace Estrace (TN) Estraderm Estraderm (TN) Estraderm MX Estraderm TTS Estraderm TTS 100 Estraderm TTS 50 Estradiol Estradiol Transdermal System Estradiol Valerate Estradiol [USAN:INN] Estradiol acetate Estradiol benzoate Estradiol cypionate Estradiol valerate Estradiol-17 beta Estradiol-17-beta Estradiol-17.beta. Estradiol-17beta Estradiol-3,17beta Estradiolo Estradiolo [DCIT] Estradiolum Estradiolum [INN] Estradot Estraldine Estrapak 50 Estrasorb Estrasorb (TN) Estreva Estrifam Estring Estring (TN) Estring Vaginal Ring Estring vaginal ring Estroclim Estroclim 50 Estrodiolum Estrofem 2 | Estrofem Forte Estrogel Estrogel (TN) Estrogel HBF Estrovite Evamist Evorel Extrasorb Femanest Femestral Femestrol Femogen Fempatch Femring Femtrace Femtran Follicyclin Gelestra Ginedisc Ginosedol GynPolar Gynergon Gynestrel Gynodiol Gynoestryl HMS1362E07 HMS1569I04 HMS1792E07 HMS1990E07 HMS2051C17 HMS2090E18 HSDB 3589 IDI1_002118 Innofem Innofem (TN) KBio2_000405 KBio2_002269 KBio2_002973 KBio2_004837 KBio2_005541 KBio2_007405 KBio3_000769 KBio3_000770 KBio3_002749 KBioGR_000405 KBioGR_002269 KBioSS_000405 KBioSS_002270 LMST02010001 LS-137 Lamdiol Lio-Oid Lopac0_000503 MLS000069494 MLS000758312 MLS001076331 Macrodiol Macrol Menest Menorest Menostar Microdiol Minivelle MolPort-001-794-632 NCGC00091544-00 NCGC00091544-01 NCGC00091544-02 NCGC00091544-04 NCGC00091544-05 NCGC00091544-06 NCGC00091544-07 NCGC00091544-08 NCGC00091544-09 NCGC00091544-12 NCGC00179321-01 NCGC00179321-02 NSC-9895 NSC9895 Nordicol Oesclim Oestergon Oestra-1,3,5(10)-triene-3,17b-diol Oestradiol Oestradiol Berco Oestradiol R Oestradiol-17-beta Oestradiol-17.beta. Oestradiol-17beta Oestradiolum Oestrogel Oestroglandol Oestrogynal Ovahormon Ovasterol Ovastevol Ovociclina Ovocyclin Ovocycline Ovocylin Perlatanol Polyestradiol Prestwick0_000441 Prestwick1_000441 Prestwick2_000441 Prestwick3_000441 Prestwick_207 Primofol Profoliol Profoliol B Progynon Progynon DH Progynon-DH S-21400 S1709_Selleck SAM001247032 SK-Estrogens SL-1100 SMP1_000121 SMR000059126 SPBio_002421 Sandrena 1 Sandrena Gel Sisare Gel Spectrum5_002055 Syndiol Systen Tradelia Trial SAT Trocosone UNII-4TI98Z838E VIVELLE-DOT Vagifem Vagifem (TN) Vivelle Vivelle (TN) Vivelle Dot Vivelle-dot Zerella Zesteem Zesteen Zumenon [2,4,6,7-3H]-E2 [3H]-estradiol [3H]]estradiol b-Estradiol beta-Estradiol beta-Estradiol 3-sulfate beta-Estradiol 3-sulphate bmse000642 cMAP_000005 cis-Estradiol cis-Oestradiol component of Menrium delta-Estradiol delta-Oestradiol estradiol estradiol-17beta nchembio.168-comp3 nchembio.76-comp2 nchembio775-comp2 nchembio794-comp6 nchembio860-comp1 progynon |
| | 44 | | Ethinyl Estradiol | approved | Phase 4, Phase 3, Phase 2 | 659 | 57-63-6 | 5991 | 17 alpha-Ethinylestradiol 17 alpha-Ethynylestradiol 17 alpha-Ethynyloestradiol 17 alpha-ethinyestradiol 17-Ethinyl-3,17-estradiol 17-Ethinyl-3,17-oestradiol 17-Ethinylestradiol 17-Ethynylestradiol 17-Ethynylestradiol ram 17-Ethynyloestradiol 17-alpha-Ethinyl-17-beta-estradiol 17-alpha-Ethynyl-17-beta-oestradiol 17-alpha-Ethynylestradiol 17-alpha-Ethynylestradiol-17-beta 17-alpha-ethynyl estradiol 17-ethinyl-3,17-estradiol 17-ethinyl-3,17-oestradiol 17-ethinylestradiol 17.alpha.-Ethinyl-17.beta.-estradiol 17.alpha.-Ethinylestradiol 17.alpha.-Ethynyl-17.beta.-oestradiol 17.alpha.-Ethynylestradiol 17.alpha.-Ethynylestradiol-l7.beta. 17.alpha.-Ethynyloestradiol 17.alpha.-Ethynyloestradiol-17.beta. 17a-Ethinyl-17b-estradiol 17a-Ethinylestradiol 17a-Ethynyl-17b-oestradiol 17a-Ethynylestradiol 17a-Ethynylestradiol-l7b 17a-Ethynyloestradiol 17a-Ethynyloestradiol-17b 17alpha-Ethinyl estradiol 17alpha-Ethinylestradiol 17alpha-Ethinylestradiol-17beta 17alpha-Ethynylestradiol 17alpha-Ethynyloestradiol 17alpha-Ethynyloestradiol-17beta 17α-ethynylestradiol 406932-93-2 46263_FLUKA 46263_RIEDEL 57-63-6 77538-56-8 AC-2169 AC1L1LK6 AI3-52941 Aethinyloestradiolum Aethinyoestradiol Aethinyoestradiol [German] Alora Amenoron Amenorone Anovlar BIDD:ER0162 BRN 2419975 Bio-0610 C07534 CCRIS 286 CHEBI:4903 CHEMBL691 CID5991 CPD000058319 Certostat Chee-O-Gen Chee-O-Genf Cyclosa D004997 D00554 DB00977 Dicromil Diognat-E Diogyn E Diogyn-E Diprol Dyloform E4876_SIGMA EE EE(sub 2) EE2 EINECS 200-342-2 EO ETHINYLESTRADIOL Effik Brand of Ethinyl Estradiol Ertonyl Esclim Esteed Estigyn Estinyl Estinyl (TN) Eston-E Estopherol Estoral Estoral (Orion) Estoral (VAN) Estoral [Orion] Estoral {[Orion]} Estorals Estradiol, Ethinyl Estradiol, Ethynyl Estring Estrogen Ethidol Ethinoral Ethinyl E2 Ethinyl Estradiol Hemihydrate Ethinyl Estradiol [USP] | Ethinyl Estradiol, (8 alpha)-Isomer Ethinyl Oestradiol Effik Ethinyl estradiol Ethinyl estradiol (USP) Ethinyl-Oestradiol Effik Ethinyl-Oestranol Ethinyl-oestranol Ethinylestradiol Ethinylestradiol (JP15/INN) Ethinylestradiol Jenapharm Ethinylestradiol [INN:BAN:JAN] Ethinylestradiolum Ethinylestradiolum [INN-Latin] Ethinylestriol Ethinyloestradiol Ethinyloestradiol [Steroidal oestrogens] Ethy 11 Ethynyl estradiol Ethynylestradiol Ethynylestradiol, Ethinyl Estradiol Ethynyloestradiol Eticyclin Eticyclol Eticylol Etinestrol Etinestryl Etinilestradiol Etinilestradiol [INN-Spanish] Etinilestradiolo Etinilestradiolo [DCIT] Etinoestryl Etistradiol Etivex Evra Feminone Fempatch Follicoral Ginestrene Gynodiol Gynolett HMS2051I19 HSDB 3587 Halodrin Hemihydrate, Ethinyl Estradiol Inestra Innofem Jenapharm Brand of Ethinyl Estradiol Jenapharm, Ethinylestradiol Kolpolyn LMST02010036 LS-231 Linoral Lynoral MLS000028479 MLS000758274 Marvelon Menolyn Menostar Mercilon Microfollin Microfollin Forte MolPort-001-794-636 NCGC00091533-01 NCGC00091533-04 NCGC00091533-05 NCI60_000234 NSC-10973 NSC10973 Neo-Estrone Nogest-S Novestrol OVULEN-21 OVULEN-28 Oradiol Orestralyn Orestrayln Organon Brand of Ethinyl Estradiol Ortho-Cyclen Ovex Oviol PUBERTAL ETHINYL ESTRADIOL STUDY Palonyl Perovex Primogyn Primogyn C Primogyn M Progynon C Progynon M Prosexol S1625_Selleck SAM001247008 SGCUT00127 SMR000058319 Schering Brand of Ethinyl Estradiol Spanestrin Thiuram E Thiuranide UNII-423D2T571U Vagifem Varnoline WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ Ylestrol component of Demulen component of Oracon component of Ortrel ethinyl estradiol ethynyl estradiol to_000048 | |
| | 45 | | Permethrin | approved, investigational | Phase 4 | 28 | 52645-53-1 | 40326 | (+)-CIS-PERMETHRIN (+)-trans-Permethrin (+-)-cis-Fmc 33297 (+-)-cis-Permethrin (+-)-trans-Permethrin (3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate 1RS,cis-Permethrin 1RS-trans-Permethrin 3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester 3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate 3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate 442748_SUPELCO 45614_FLUKA 45614_RIEDEL 45893_FLUKA 45893_RIEDEL 47956_SUPELCO 52341-32-9 52341-33-0 52645-53-1 AC1L23IC AC1Q3FFG AI3-29296 Acticin Cream Ambush BRN 4153590 C21H20Cl2O3 CHEBI:34911 CHEMBL1525 CID40326 DB04930 Elimite Elimite Cream Equaline Lice Treatment FMC 35171 | Good Neighbor Pharmacy Lice Treatment Good Sense Lice Treatment LS-58636 LS-58640 Leader Lice Treatment Lice Treatment MLS001332525 MLS001332526 MolPort-003-933-021 NCGC00159390-00 NCGC00159390-02 NCGC00159390-04 NCGC00159390-05 NCGC00159390-06 NCGC00159390-07 NCGC00159390-08 NCGC00159390-09 NRDC 146 NRDC 148 Nix Nix Complete Maximum Strength Lice Elimination Nix Cream Rinse PS758_SUPELCO PerFoam Permethrin Permethrin (isomers) Permethrin (isomers) solution Permethrine,c&t SMR000778043 ST50975270 Smart Sense Lice Treatment TL8003462 Topcare Lice Treatment Transpermethrin Transpermethrin [ISO] [3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate trans-(+-)-Permethrin | |
| | 46 | | Pilocarpine | approved | Phase 4, Phase 3 | 24 | 54-71-7 | 5910 | (+)-Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one (3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone (3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone 3-Ethyl-4-(3-methyl-3H-imidazol-4-ylmethyl)dihydrofuran-2-one 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one 3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydro-2(3H)-furanone 3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one 54-71-7 91484-73-0 92-13-7 AC1L1J0W AC1L1LEF AC1Q6MOP AI3-50523 AR-1F3128 Adsorbocarpine Almocarpine Amistura P BIDD:GT0217 BPBio1_000548 BRD-K85090592-008-05-2 BSPBio_000498 BSPBio_002191 C07474 CHEBI:39460 CHEBI:8207 CHEMBL550 CID4819 CID5910 D00525 DB01085 DivK1c_000358 EINECS 202-128-4 Epicar HMS2089K17 HSDB 3163 IDI1_000358 Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone Isopto carpine Isoptocarpine KBio1_000358 KBio2_001587 KBio2_004155 KBio2_006723 KBio3_001691 KBioGR_000956 KBioSS_001587 L001181 LS-187208 LS-7661 Lopac0_000950 Lopac0_000960 Mi-Pilo Minims Pilocarpine Miocarpine MolPort-002-512-506 NCGC00023339-03 NCGC00023339-06 | NCGC00023339-07 NCGC00023339-08 NCGC00023339-09 NCGC00023339-12 NCGC00023339-13 NCI60_004403 NINDS_000358 NSC5746 Ocu-Carpine Ocusert Ocusert P 20 Ocusert Pilo-40 Ocusert pilo Ocusert pilo-20 Ocusert pilo-20 (TN) P.V. Carpine Liquifilm Pilagan Pilocarpin Pilocarpine Pilocarpine (JAN/USP) Pilocarpine HCl Pilocarpine Hydrochloride Pilocarpine Mononitrate, (3S-cis)-Isomer Pilocarpine [USAN:BAN:JAN] Pilocarpine chloride Pilocarpine hydrochloride Pilocarpine monohydrochloride Pilocarpine muriate Pilocarpine nitrate Pilocarpine, Monohydrochloride, (3S-cis)-Isomer Pilocarpol Pilokarpin Pilokarpin monohydrochloride Pilokarpol Piloptic-1 Piloptic-1/2 Piloptic-2 Piloptic-3 Piloptic-4 Piloptic-6 Pilostat Prestwick0_000449 Prestwick1_000449 Prestwick2_000449 Prestwick3_000449 SDCCGMLS-0003164.P005 SPBio_001287 SPBio_002437 STOCK1N-18408 Salagen Spectrum2_001284 Spectrum3_000546 Spectrum4_000478 Spectrum5_001379 Spectrum_001107 Spersacarpine Spersacarpine hydrochloride Syncarpine Tocris-0694 UNII-01MI4Q9DI3 ZINC00075008 beta-Pilocarpine hydrochloride isopilocarpine nchembio.78-comp9 pilocarpine | |
| | 47 | | Montelukast | approved | Phase 4 | 264 | 158966-92-8 | 5281040 | (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid (R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid 1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid 151767-02-1 (sodium) 158966-92-8 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid AC1NQXXW Apxi toxin BIDD:GT0394 Brondilat Brondilat (TN) C07482 C35H36ClNO3S CHEBI:50730 CHEMBL787 CID5281040 D08229 | DB00471 HMS2089D07 HSDB 7582 LS-173539 MK 0476 MK-0476 Montair Montelukast Montelukast (INN) Montelukast Sodium Montelukast [INN:BAN] Montelukast sodium Montelukastum Montélukast Singulair Singular UNII-MHM278SD3E montelukast sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid |
| | 48 | | rituximab | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1582 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 49 | | Doxycycline | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 219 | 564-25-0 | 54671203, 5281011 | (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 10597-92-9 17086-28-1 (mono-hydrate) 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS) 24390-14-5 41411-66-9 (6-epimer, mono-hydrochloride) 5-Hydroxy-alpha-6-deoxytetracycline 564-25-0 6-Deoxyoxytetracycline 6-Deoxytetracycline 6-alpha-Deoxy-5-oxytetracycline 6-alpha-deoxy-5-oxytetracycline 69935-17-7 (mono-hydrochloride, di-hydrate) 6alpha-Deoxy-5-oxytetracycline 6α-deoxy-5-oxytetracycline 7164-70-7 7264-10-0 94088-85-4 (calcium salt (1:2)) AB08 (*Fosfatex) AC1NQXW7 AC1NS4CW AC1NUYS8 AC1O8PYM Adoxa Alodox Alti-Doxycycline Apo-Doxy Atridox Azudoxat BCBcMAP01_000024 BIDD:GT0146 BMY-28689 BPBio1_000951 BSPBio_000863 BSPBio_001936 BU-3839T C06973 CHEBI:50845 CHEMBL1433 CID5281011 CID5353597 CID5463943 CID6713981 CPD001550033 D07876 DB00254 DMSC (*Fosfatex) DOXCYCLINE ANHYDROUS DOXY DOXYCYCLINE CALCIUM DOXYCYCLINE MONOHYDRATE Deoxymykoin DivK1c_000345 Doryx Dossiciclina Dossiciclina [DCIT] Doxcycline anhydrous Doxiciclina Doxiciclina [INN-Spanish] Doxiciclina [Italian] Doxitard Doxivetin Doxy 100 Doxy-Caps Doxy-Puren Doxy-Tabs Doxycen Doxychel Doxychel (TN) Doxycin Doxycyclin Doxycycline Doxycycline (200mg/day) or Placebo Doxycycline (INN) | Doxycycline (TN) Doxycycline (anhydrous) Doxycycline (internal use) Doxycycline Hyclate Doxycycline Monohydrate Doxycycline anhydrous Doxycycline hyclate Doxycycline hydrochloride Doxycycline-Chinoin Doxycyclinum Doxycyclinum [INN-Latin] Doxysol Doxytec Doxytetracycline EINECS 209-271-1 GS-3065 (*monohydrate) HMS2090E06 HSDB 3071 Hydramycin IDI1_000345 Investin Jenacyclin KBio1_000345 KBio2_001287 KBio2_003855 KBio2_006423 KBio3_001156 KBioGR_001133 KBioSS_001287 LS-187766 LS-93868 Liviatin Lopac0_000405 MolPort-002-507-423 Monodox Monodox (*monohydrate) Morgidox NCGC00161602-01 NCGC00161602-03 NCGC00161602-04 NCGC00167961-01 NCGC00179395-01 NINDS_000345 NSC633557 Novo-Doxylin Nu-Doxycycline Ocudox Oracea Prestwick0_000852 Prestwick1_000852 Prestwick2_000852 Prestwick3_000852 Ronaxan SAM002589932 SMP1_000107 SPBio_000246 SPBio_002784 STOCK1N-34341 Spanor Spectrum2_000143 Spectrum3_000408 Spectrum4_000527 Spectrum5_000947 Spectrum_000807 Supracyclin UNII-334895S862 UPCMLD-DP021 UPCMLD-DP021:001 Vibra-tabs Vibramycin Vibramycin (*monohydrate) Vibramycin Monohydrate Vibramycin Novum Vibramycine Vibravenos Vivox (*Hyclate) alpha-6-Deoxy-5-hydroxytetracycline alpha-6-Deoxyoxytetracycline alpha-Doxycycline doxycycline | |
| | 50 | | Minocycline | approved, investigational | Phase 4, Phase 1, Phase 2 | 173 | 10118-90-8 | 5281021 | (2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE (4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 10118-90-8 13614-98-7 (mono-hydrochloride) 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide 4708-96-7 7-Dimethylamino-6-demethyl-6-deoxytetracycline AC1NQXWM Arestin BRN 3077644 Bio-0062 Borymycin C07225 C23H27N3O7 CHEBI:50694 CHEBI:529981 CHEMBL1434 CHEMBL259172 CID5281021 CL 59806 CRL-1605 & Minocycline D05045 Dynacin HMS2090D03 HSDB 3130 LMPK07000002 | LS-93850 Lactoferrin B & Minocycline Lactoferrin H & Minocycline MINO MIY Minociclina Minociclina [INN-Spanish] Minociclinum Minocin Minocin (Hydrochloride) Minocline Minocyclin Minocycline Minocycline (USAN/INN) Minocycline Hydrochloride Minocycline Monohydrochloride Minocycline [USAN:BAN:INN] Minocyclinum Minocyclinum [INN-Latin] NCGC00178854-01 NSC 141993 NSC141993 Solodyn UNII-FYY3R43WGO Vectrin (Hydrochloride) Ximino minociclinum minocycline nchembio.559-comp1 |
|
Interventional clinical trials: (show top 50)
(show all 5000)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease | Completed | NCT00567177 | Phase 4 | | 2 | Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) | Completed | NCT01458600 | Phase 4 | | 3 | The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease | Completed | NCT02120079 | Phase 4 | | 4 | Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) | Completed | NCT02059655 | Phase 4 | | 5 | Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections | Completed | NCT01599273 | Phase 4 | | 6 | A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease | Completed | NCT01014078 | Phase 4 | | 7 | Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis | Completed | NCT00407043 | Phase 4 | | 8 | Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase | Completed | NCT00520260 | Phase 4 | | 9 | Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) | Completed | NCT00913029 | Phase 4 | | 10 | A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma | Completed | NCT00911924 | Phase 4 | | 11 | Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® | Completed | NCT00799682 | Phase 4 | | 12 | Comparison of Autologous Serum Versus Preservative Free Artificial Tear | Completed | NCT02752763 | Phase 4 | | 13 | Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans | Completed | NCT00312325 | Phase 4 | | 14 | Efficacy of Changing to TRAVATAN® From Prior Therapy | Completed | NCT01510145 | Phase 4 | | 15 | Steroids for Corneal Ulcers Trial | Completed | NCT00324168 | Phase 4 | | 16 | Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO | Completed | NCT01580020 | Phase 4 | | 17 | Trachoma Amelioration in Northern Amhara (TANA) | Completed | NCT00322972 | Phase 4 | | 18 | Tripartite International Research for the Elimination of Trachoma | Completed | NCT01202331 | Phase 4 | | 19 | TearLab Refractive Surgery Dry Eye Study | Completed | NCT01176045 | Phase 4 | | 20 | Ranibizumab "Treat and Extend" in Diabetic Macular Edma | Completed | NCT01297569 | Phase 4 | | 21 | Efficacy and Acceptability of Two Lubricant Eye Drops | Completed | NCT00756678 | Phase 4 | | 22 | Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy | Completed | NCT02121847 | Phase 4 | | 23 | Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms | Completed | NCT00938704 | Phase 4 | | 24 | Ocular Responses to Short and Long-term Lens Wear | Completed | NCT00722891 | Phase 4 | | 25 | Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome | Completed | NCT01864330 | Phase 4 | | 26 | Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome | Completed | NCT02585453 | Phase 4 | | 27 | A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye | Completed | NCT00399230 | Phase 4 | | 28 | Vitamin A and Very Low Birthweight Babies (VitAL) | Completed | NCT00417404 | Phase 4 | | 29 | Intraductal Meibomian Gland Probing Trial | Completed | NCT02256969 | Phase 4 | | 30 | The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye | Completed | NCT00553735 | Phase 4 | | 31 | Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases | Completed | NCT00404729 | Phase 4 | | 32 | Prevalence of Ocular Surface Disease in Glaucoma Patients | Completed | NCT00382122 | Phase 4 | | 33 | Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty | Completed | NCT01853696 | Phase 4 | | 34 | The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction | Completed | NCT00717080 | Phase 4 | | 35 | A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction | Completed | NCT00654082 | Phase 4 | | 36 | Fuchs' Torsional Phaco Study | Completed | NCT00781027 | Phase 4 | | 37 | Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops | Completed | NCT02758327 | Phase 4 | | 38 | Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients | Completed | NCT01682460 | Phase 4 | | 39 | Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye | Completed | NCT00987727 | Phase 4 | | 40 | Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases | Completed | NCT01091311 | Phase 4 | | 41 | Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases | Completed | NCT01189474 | Phase 4 | | 42 | A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms | Completed | NCT02028754 | Phase 4 | | 43 | A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye | Completed | NCT02117687 | Phase 4 | | 44 | An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® | Completed | NCT01664039 | Phase 4 | | 45 | Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints | Completed | NCT01543061 | Phase 4 | | 46 | Effects of Travatan Z and Xalatan on Ocular Surface Health | Completed | NCT00708422 | Phase 4 | | 47 | Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN | Completed | NCT00798759 | Phase 4 | | 48 | Spherical Aberration and Contrast Sensitivity in IOLs | Completed | NCT00576485 | Phase 4 | | 49 | A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) | Completed | NCT00304291 | Phase 4 | | 50 | Efficacy of Changing to DUOTRAV® From Prior Therapy | Completed | NCT01327599 | Phase 4 |
Inferred drug relations via UMLS65/NDF-RT43:
|
